<SEC-DOCUMENT>0001193125-23-140708.txt : 20230510
<SEC-HEADER>0001193125-23-140708.hdr.sgml : 20230510
<ACCEPTANCE-DATETIME>20230510160705
ACCESSION NUMBER:		0001193125-23-140708
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230509
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230510
DATE AS OF CHANGE:		20230510

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			COMMUNITY HEALTH SYSTEMS INC
		CENTRAL INDEX KEY:			0001108109
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062]
		IRS NUMBER:				133893191
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-15925
		FILM NUMBER:		23906343

	BUSINESS ADDRESS:	
		STREET 1:		4000 MERIDIAN BOULEVARD
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067
		BUSINESS PHONE:		615-465-7000

	MAIL ADDRESS:	
		STREET 1:		4000 MERIDIAN BOULEVARD
		CITY:			FRANKLIN
		STATE:			TN
		ZIP:			37067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COMMUNITY HEALTH SYSTEMS INC/
		DATE OF NAME CHANGE:	20000229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d274455d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cyh="http://www.chs.net/20230509" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>Form 8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2023-05-09_to_2023-05-09">COMMUNITY HEALTH SYSTEMS INC</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-05-09_to_2023-05-09">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-05-09_to_2023-05-09">0001108109</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="cyh-20230509.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-05-09_to_2023-05-09"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001108109</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-09</xbrli:startDate> <xbrli:endDate>2023-05-09</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-05-09_to_2023-05-09">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (date of earliest event reported): May&#160;10, 2023 (<ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-05-09_to_2023-05-09" format="ixt:datemonthdayyearen">May 9, 2023</ix:nonNumeric>)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">COMMUNITY HEALTH SYSTEMS, INC.</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-05-09_to_2023-05-09" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-05-09_to_2023-05-09">001-15925</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-05-09_to_2023-05-09">13-3893191</ix:nonNumeric><br /></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">incorporation or organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br />Identification No.)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-05-09_to_2023-05-09">4000 Meridian Boulevard</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-05-09_to_2023-05-09">Franklin</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-05-09_to_2023-05-09" format="ixt-sec:stateprovnameen">Tennessee</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-05-09_to_2023-05-09">37067</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-05-09_to_2023-05-09">(615)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-05-09_to_2023-05-09">465-7000</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-05-09_to_2023-05-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-05-09_to_2023-05-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-05-09_to_2023-05-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-05-09_to_2023-05-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-05-09_to_2023-05-09">Common Stock, $0.01 par value</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-05-09_to_2023-05-09">CYH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-05-09_to_2023-05-09" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-05-09_to_2023-05-09" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.02.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><span style="text-decoration:underline">Approval of Amended and Restated 2009 Stock Option and Award Plan </span></p> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting of the Stockholders (the &#8220;Annual Meeting&#8221;) of Community Health Systems, Inc. (the &#8220;Company&#8221;) held on May&#160;9, 2023, the Company&#8217;s stockholders approved the amendment and restatement of the Company&#8217;s 2009 Stock Option and Award Plan, as approved by the Company&#8217;s Board of Directors on March&#160;22, 2023, subject to stockholder approval at the Annual Meeting (the &#8220;Plan&#8221;). The results of the stockholder vote on the Plan are set forth further below under Item 5.07 of this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A description of the Plan was included as part of Proposal&#160;4 in the Company&#8217;s proxy statement filed on March&#160;30, 2023 (the &#8220;Proxy Statement&#8221;) and is incorporated herein by reference. Such description is qualified in its entirety by reference to the text of the Plan, a copy of which is filed as Exhibit 10.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;5.07.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Submission of Matters to a Vote of Security Holders. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the Annual Meeting, the Company&#8217;s stockholders voted on five proposals, each of which is described more fully in the Company&#8217;s Proxy Statement for the Annual Meeting. The following describes the matters that were submitted to the vote of the stockholders of the Company at the Annual Meeting and the result of the votes on these matters: </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) The stockholders elected each of the following persons as directors of the Company for terms that expire at the 2024 annual meeting of stockholders of the Company and until their respective successors have been elected and have qualified: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:58%"></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>

<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Name</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">For</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Against</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Abstain</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"><span style="font-weight:bold">Broker<br /><span style="white-space:nowrap">Non-Votes</span></span></td>
<td style="vertical-align:bottom">&#160;</td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(a) Susan W. Brooks</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">90,250,840</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">3,636,331</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56,111</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(b) John A. Clerico</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">91,610,832</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,276,508</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">55,942</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(c) Michael Dinkins</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">93,219,143</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">669,705</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">54,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(d) James S. Ely III</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">82,689,866</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,291,112</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,962,304</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(e) John A. Fry</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">83,133,660</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">10,753,725</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">55,897</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(f) Joseph A. Hastings, D.M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">92,097,000</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,792,516</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">53,766</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(g) Tim L. Hingtgen</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">92,300,759</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,588,253</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">54,270</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(h) Elizabeth T. Hirsch</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">93,176,004</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">711,038</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">56,240</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(i) William Norris Jennings, M.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">82,517,136</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,463,992</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,962,154</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(j) K. Ranga Krishnan, MBBS</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">92,203,579</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">1,682,276</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">57,427</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(k) Wayne T. Smith</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">82,593,318</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">2,383,135</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,966,829</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(l) H. James Williams, Ph.D.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">84,337,120</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">644,314</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">8,961,848</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom" align="right">15,873,434</td>
<td style="white-space:nowrap;vertical-align:bottom">&#160;</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) The stockholders approved the advisory resolution regarding the Company&#8217;s executive compensation: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">92,305,284</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">1,556,801</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">81,197</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">15,873,434</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) The stockholders approved, on an advisory basis, the holding of future advisory votes on executive compensation every one year: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">


<tr>

<td style="width:18%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:19%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:20%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:20%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:19%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">1 Year</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">2 Years</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">3 Years</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">91,381,958</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">25,203</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2,452,171</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">83,950</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">15,873,434</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) The stockholders approved the amendment and restatement of the Company&#8217;s 2009 Stock Option and Award Plan, as approved by the Company&#8217;s Board of Directors as of March&#160;22, 2023, subject to stockholder approval at the Annual Meeting: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">91,119,075</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">2,769,969</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">54,238</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center">15,873,434</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(5) The stockholders ratified the appointment of Deloitte&#160;&amp; Touche LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December&#160;31, 2023: </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt;width:92%;border:0;margin:0 auto">


<tr>

<td style="width:24%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:24%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:25%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:24%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">For</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Against</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Abstain</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap">Broker&#160;Non-Votes</span></p></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt;background-color:#cceeff">
<td style="vertical-align:bottom" align="center">108,256,727</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">1,482,141</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" align="center">77,848</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top" align="center">n/a</td></tr>
</table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In light of the voting results with respect to the frequency of future advisory votes on executive compensation as set forth above and the Company&#8217;s Board of Directors&#8217; recommendation that stockholders vote to hold future advisory votes on executive compensation every one year, the Company will continue to hold advisory votes on executive compensation every one year until the next required advisory vote on the frequency of such votes. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements&#160;&amp; Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&#160;&#160; Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Number</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">10.1&#8224;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d274455dex101.htm">Community Health Systems, Inc. 2009 Stock Option and Award Plan, as amended and restated as of March&#160;22, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table> <p style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top" align="left">&#8224;</td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Indicates a management contract or compensatory plan or arrangement </p></td></tr></table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom" colspan="3">Date: May&#160;10, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3">COMMUNITY HEALTH SYSTEMS, INC</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td colspan="3" style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap">(Registrant)</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&#160;&#160;/s/ Christopher G. Cobb</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;&#160;&#160;Christopher G. Cobb</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">&#160;&#160;&#160;&#160;Vice President &#8211; Legal and Corporate Secretary</td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">4 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>d274455dex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Community Health Systems, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2009 STOCK OPTION AND AWARD PLAN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(As Adopted March&nbsp;24, 2009 and Amended and Restated March&nbsp;18, 2011,&nbsp;March&nbsp;20, 2013, March&nbsp;19, 2014, March&nbsp;16,
2016, March&nbsp;14, 2018, March&nbsp;20, 2020, March&nbsp;17, 2021 and March&nbsp;22, 2023) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. Purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The purpose of this Plan is to strengthen Community Health Systems, Inc., a Delaware corporation (the &#147;Company&#148;), and its
Subsidiaries by providing a retention tool and an incentive to its and their employees, officers, consultants and directors, and thereby encouraging them to devote their abilities and industry to the success of the Company&#146;s and its
Subsidiaries&#146; business enterprises. It is intended that this purpose be achieved by extending to employees (including future employees who have received a formal written offer of employment), officers, consultants and directors of the Company
and its Subsidiaries an added long-term incentive for high levels of performance and unusual efforts through the grant of Incentive Stock Options, <FONT STYLE="white-space:nowrap">Non-qualified</FONT> Stock Options, Stock Appreciation Rights,
Performance Units, Performance Shares, Other Share Awards, Restricted Stock and Restricted Stock Units (as each term is herein defined). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. Definitions.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of the Plan: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 &#147;Affiliate&#148; means any entity, directly or indirectly, controlled by, controlling or under common control with the Company or any
corporation or other entity acquiring, directly or indirectly, all or substantially all the assets and business of the Company, whether by operation of law or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 &#147;Agreement&#148; means the written agreement between the Company and an Optionee or Grantee evidencing the grant of an Option or
Award and setting forth the terms and conditions thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 &#147;Award&#148; means a grant of an Option, Restricted Stock, a
Restricted Stock Unit, a Stock Appreciation Right, a Performance Award, an Other Share Award or any or all of them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 &#147;Board&#148;
means the Board of Directors of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 &#147;Cause&#148; means, except as otherwise set forth herein or in an applicable
Agreement, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) in the case of an Optionee or Grantee whose employment with the Company or a Subsidiary is subject to the terms of an
employment agreement between such Optionee or Grantee and the Company or Subsidiary, which employment agreement includes a definition of &#147;Cause&#148;, the term &#147;Cause&#148; as used in this Plan or any Agreement shall have the meaning set
forth in such employment agreement during the period that such employment agreement remains in effect; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) in all other cases, (i)&nbsp;intentional failure to perform reasonably assigned duties,
(ii)&nbsp;dishonesty or willful misconduct in the performance of duties, (iii)&nbsp;involvement in a transaction in connection with the performance of duties to the Company or any of its Subsidiaries which transaction is adverse to the interests of
the Company or any of its Subsidiaries and which is engaged in for personal profit or (iv)&nbsp;willful violation of any law, rule or regulation in connection with the performance of duties (other than traffic violations or similar offenses);
provided, however, that, following a Change in Control, clause (i)&nbsp;of this Section&nbsp;2.5(b) shall not constitute &#147;Cause.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 &#147;Change in Capitalization&#148; means any increase or reduction in the number of Shares, or any change (including, but not limited
to, in the case of a <FONT STYLE="white-space:nowrap">spin-off,</FONT> dividend or other distribution in respect of Shares, a change in value) in the Shares or exchange of Shares for a different number or kind of shares or other securities of the
Company or another corporation, by reason of a reclassification, recapitalization, merger, consolidation, reorganization, <FONT STYLE="white-space:nowrap">spin-off,</FONT> <FONT STYLE="white-space:nowrap">split-up,</FONT> issuance of warrants or
rights or debentures, stock dividend, stock split or reverse stock split, property dividend, extraordinary cash dividend (but excluding normal cash dividends), combination or exchange of shares, repurchase of shares, change in corporate structure,
equity restructuring (as defined under FASB ASC Topic 718) or similar transaction or event. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 A &#147;Change in Control&#148; shall
mean the occurrence of any of the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) An acquisition (other than directly from the Company) of any voting securities of the
Company (the &#147;Voting Securities&#148;) by any &#147;Person&#148; (as the term person is used for purposes of Section&nbsp;13(d) or 14(d) of the Exchange Act), immediately after which such Person has &#147;Beneficial Ownership&#148; (within the
meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> promulgated under the Exchange Act) of more than fifty percent (50%)&nbsp;of the then outstanding Shares or the combined voting power of the Company&#146;s then outstanding Voting
Securities; <I>provided</I>, <I>however</I>, that in determining whether a Change in Control has occurred pursuant to this Section&nbsp;2.7(a), Shares or Voting Securities which are acquired in a
<FONT STYLE="white-space:nowrap">&#147;Non-Control</FONT> Acquisition&#148; (as hereinafter defined) shall not constitute an acquisition which would cause a Change in Control. A <FONT STYLE="white-space:nowrap">&#147;Non-Control</FONT>
Acquisition&#148; shall mean an acquisition by (i)&nbsp;an employee benefit plan (or a trust forming a part thereof) maintained by (A)&nbsp;the Company or (B)&nbsp;any corporation or other Person the majority of the voting power, voting equity
securities or equity interest of which is owned, directly or indirectly, by the Company (for purposes of this definition, a &#147;Related Entity&#148;), (ii)&nbsp;the Company or any Related Entity, or (iii)&nbsp;any Person in connection with a <FONT
STYLE="white-space:nowrap">&#147;Non-Control</FONT> Transaction&#148; (as hereinafter defined); </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The individuals who, as of the
Restatement Effective Date, are members of the Board (the &#147;Incumbent Board&#148;), cease for any reason to constitute at least a majority of the members of the Board or, following a Merger (as hereinafter defined) which results in a Parent
Corporation (as hereinafter defined), the board of directors of the ultimate Parent Corporation; provided, however, that if the election, or nomination for election by the Company&#146;s common stockholders, of any new director was approved by a
vote of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the Incumbent Board, such new director shall, for purposes of this Plan, be considered a member of the Incumbent Board; <I>provided further</I>, however, that no individual shall
be considered a member of the Incumbent Board if such individual initially assumed office as a result of the actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board (a &#147;Proxy Contest&#148;)
including by reason of any agreement intended to avoid or settle any Proxy Contest; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The consummation of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) A merger, consolidation or reorganization with or into the Company or in which securities of the Company are issued (a
&#147;Merger&#148;), unless such Merger is a <FONT STYLE="white-space:nowrap">&#147;Non-Control</FONT> Transaction.&#148; A <FONT STYLE="white-space:nowrap">&#147;Non-Control</FONT> Transaction&#148; shall mean a Merger where: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(A) the stockholders of the Company immediately before such Merger own directly or indirectly immediately following such Merger
at least fifty percent (50%)&nbsp;of the combined voting power of the outstanding voting securities of (x)&nbsp;the corporation or other entity resulting from such Merger (the &#147;Surviving Corporation&#148;), if fifty percent (50%)&nbsp;or more
of the combined voting power of the then outstanding voting securities of the Surviving Corporation is not Beneficially Owned, directly or indirectly, by another Person (a &#147;Parent Corporation&#148;), or (y)&nbsp;if there is one or more than one
Parent Corporation, the ultimate Parent Corporation; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(B) the individuals who were members of the Incumbent Board
immediately prior to the execution of the agreement providing for such Merger constitute at least a majority of the members of the board of directors of (x)&nbsp;the Surviving Corporation, if there is no Parent Corporation, or (y)&nbsp;if there is
one or more than one Parent Corporation, the ultimate Parent Corporation; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) A complete liquidation or dissolution of
the Company; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) The sale or other disposition of all or substantially all of the assets of the Company to any Person
(other than a transfer to a Related Entity or under conditions that would constitute a <FONT STYLE="white-space:nowrap">Non-Control</FONT> Transaction with the disposition of assets being regarded as a Merger for this purpose or the distribution to
the Company&#146;s stockholders of the stock of a Related Entity or any other assets). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, (A)&nbsp;a Change
in Control shall not be deemed to occur solely because any Person (the &#147;Subject Person&#148;) acquired Beneficial Ownership of more than the permitted amount of the then outstanding Shares or Voting Securities as a result of the acquisition of
Shares or Voting Securities by the Company which, by reducing the number of Shares or Voting Securities then outstanding, increases the proportional number of shares Beneficially Owned by the Subject Persons, provided that if a Change in Control
would occur (but for the operation of this sentence) as a result of the acquisition of Shares or Voting Securities by the Company, and after such share acquisition by the Company, the Subject Person becomes the Beneficial Owner of any additional
Shares or Voting Securities which increases the percentage of the then outstanding Shares or Voting Securities Beneficially Owned by the Subject Person, then a Change in Control shall occur; and (B)&nbsp;with respect to any Award constituting a
&#147;deferral of compensation&#148; subject to Section&nbsp;409A of the Code, solely for purposes of determining the timing of a payment pursuant to the Agreement, a Change in Control shall mean a &#147;change in the ownership&#148; of the Company,
a &#147;change in the effective control&#148; of the Company, or a &#147;change in the ownership of a substantial portion of the assets&#148; of the Company as such terms are defined in
<FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)</FONT> of the Treasury Regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If an Optionee&#146;s or Grantee&#146;s
employment is terminated by the Company without Cause prior to the date of a Change in Control but the Optionee or Grantee reasonably demonstrates that the termination (A)&nbsp;was at the request of a third party who has indicated an intention or
taken steps reasonably calculated to effect a Change in Control or (B)&nbsp;otherwise arose in connection with, or in anticipation of, a Change in Control which has been threatened or proposed, such termination shall be deemed to have occurred after
a Change in Control for purposes of this Plan provided a Change in Control shall actually have occurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 &#147;Code&#148; means the Internal Revenue Code of 1986, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9 &#147;Committee&#148; means a committee, as described in Section&nbsp;3.1, appointed by the Board from time to time to administer the Plan
and to perform the functions set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10 &#147;Company&#148; means Community Health Systems, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.11 &#147;Director&#148; means a director of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.12 &#147;Disability&#148; means, unless otherwise defined in an Agreement: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) in the case of an Optionee or Grantee whose employment with the Company or a Subsidiary is subject to the terms of an employment agreement
between such Optionee or Grantee and the Company or Subsidiary, which employment agreement includes a definition of &#147;Disability&#148;, the term &#147;Disability&#148; as used in this Plan or any Agreement shall have the meaning set forth in
such employment agreement during the period that such employment agreement remains in effect; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) in the case of an Optionee or Grantee
to whom Section&nbsp;2.12(a) does not apply and who participates in the Company&#146;s long-term disability plan, if any, the term &#147;Disability&#148; as used in such plan; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) in all other cases, a physical or mental infirmity which impairs the Optionee&#146;s or Grantee&#146;s ability to perform substantially
all his or her duties for a period of <FONT STYLE="white-space:nowrap">ninety-one</FONT> (91)&nbsp;consecutive days. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.13
&#147;Division&#148; means any of the operating units or divisions of the Company designated as a Division by the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.14
&#147;Dividend Equivalent Right&#148; means a right to receive all or some portion of the cash dividends that are or would be payable with respect to Shares; provided, that subject to Section&nbsp;12, no Dividend Equivalent Rights shall be granted
with respect to unexercised Options or Stock Appreciation Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.15 &#147;Eligible Individual&#148; means any of the following
individuals who is designated by the Committee as eligible to receive Options or Awards subject to the conditions set forth herein: (a)&nbsp;any Director or Employee, (b)&nbsp;any individual to whom the Company or a Subsidiary has extended a formal,
written offer of employment (provided that the grant of an Option or Award to any such individual is made following the commencement of employment), or (c)&nbsp;any consultant or advisor (within the scope of Instruction A.1.(a)(1) of Form <FONT
STYLE="white-space:nowrap">S-8</FONT> under the Securities Act of 1933, as amended) of the Company or a Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.16
&#147;Employee&#148; means any person, including an officer (whether or not also a director) in the regular full-time employment of the Company or any of its Subsidiaries, but excludes, in the case of an Incentive Stock Option, an employee of any
Subsidiary that is not a &#147;subsidiary corporation&#148; of the Company as defined in Code Section&nbsp;424(f). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.17 &#147;Exchange Act&#148; means the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.18 &#147;Fair Market Value&#148; on any date, unless otherwise determined by the Committee, means the closing sales prices of the Shares on
such date on the principal national securities exchange on which such Shares are listed or admitted to trading, or, if such Shares are not so listed or admitted to trading, the closing sales prices of the Shares as reported by the New York Stock
Exchange at the close of the primary trading session on such dates and, in either case, if the Shares were not traded on such date, on the next preceding day on which the Shares were traded. In the event that Fair Market Value cannot be determined
in a manner described above, the Fair Market Value shall be the value established by the Board in good faith. The determination of Fair Market Value for purposes of income tax withholding may be made in the Committee&#146;s discretion subject to
applicable legal requirements and is not required to be consistent with the determination of Fair Market Value for other purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.19
For purposes of this Plan, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) &#147;Good Reason&#148; shall mean, unless otherwise provided in an Agreement, the occurrence after a
Change in Control of any of the following events or conditions with respect to an Optionee or Grantee: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) a change in the
Optionee&#146;s or Grantee&#146;s status, title, position or responsibilities (including reporting responsibilities) which, in the Optionee&#146;s or Grantee&#146;s reasonable judgment, represents an adverse change from the Optionee&#146;s or
Grantee&#146;s status, title, position or responsibilities as in effect immediately prior thereto; the assignment to the Optionee or Grantee of any duties or responsibilities which, in the Optionee&#146;s or Grantee&#146;s reasonable judgment, are
inconsistent with the Optionee&#146;s or Grantee&#146;s status, title, position or responsibilities; or any removal of the Optionee or Grantee from or failure to reappoint or reelect the Optionee or Grantee to any of such offices or positions,
except in connection with the termination of the Optionee&#146;s or Grantee&#146;s employment for Disability, Cause, as a result of the Optionee&#146;s or Grantee&#146;s death or by the Optionee or Grantee other than for Good Reason; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) a reduction in the Optionee&#146;s or Grantee&#146;s annual base salary below the amount as in effect immediately prior to
the Change in Control; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the relocation of the Optionee&#146;s or Grantee&#146;s primary place of employment to a
location more than twenty-five (25)&nbsp;miles from the location of the Optionee&#146;s or Grantee&#146;s primary place of employment immediately prior to such Change in Control, or requiring the Optionee or Grantee to be based anywhere other than
such offices, except to the extent the Optionee or Grantee was not previously assigned to a principal location and except for required travel on business to the extent substantially consistent with the Optionee&#146;s or Grantee&#146;s business
travel obligations at the time of the Change in Control; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) the failure to pay to the Optionee or Grantee any portion of
the Optionee&#146;s or Grantee&#146;s current compensation or to pay to the Optionee or Grantee any portion of an installment of deferred compensation under any deferred compensation program of the Company or any of its Subsidiaries in which the
Optionee or Grantee participated, within seven (7)&nbsp;days of the date such compensation is due; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) the failure to (A)&nbsp;continue in effect (without reduction in benefit
level, and/or reward opportunities) any material compensation or employee benefit plan in which the Optionee or Grantee was participating immediately prior to the Change in Control, unless a substitute or replacement plan has been implemented which
provides substantially identical compensation or benefits to the Optionee or Grantee or (B)&nbsp;provide the Optionee or Grantee with compensation and benefits, in the aggregate, at least equal (in terms of benefit levels and/or reward
opportunities) to those provided for under each other compensation or employee benefit plan, program and practice in which the Optionee or Grantee was participating immediately prior to the Change in Control; or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) the failure of the Company to obtain from its successors or assigns the express assumption and agreements to the extent
required under Section&nbsp;13 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Any event or condition described in Section&nbsp;2.19(a)(i), (ii), (iii), (iv), or
(vi),&nbsp;which occurs at any time prior to the date of a Change in Control and (1)&nbsp;which occurred after the Company entered into a definitive agreement, the consummation of which would constitute a Change in Control or (2)&nbsp;which the
Optionee or Grantee reasonably demonstrates was at the request of a third party who has indicated an intention or has taken steps reasonably calculated to effect a Change in Control, shall constitute Good Reason for purposes of this Agreement,
notwithstanding that it occurred prior to a Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.20 &#147;Grantee&#148; means a person to whom an Award has been granted
under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.21 &#147;Grant Price&#148; means the price established at the time of a grant of a Stock Appreciation Right used to
determine whether there is any payment due upon exercise of the Stock Appreciation Right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.22 &#147;Incentive Stock Option&#148; means
an Option satisfying the requirements of Section&nbsp;422 of the Code and designated by the Committee as an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.23 <FONT
STYLE="white-space:nowrap">&#147;Non-Employee</FONT> Director&#148; means a Director who is not an employee of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.24 <FONT
STYLE="white-space:nowrap">&#147;Non-qualified</FONT> Stock Option&#148; means an Option which is not an Incentive Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.25
&#147;Option&#148; means a <FONT STYLE="white-space:nowrap">Non-qualified</FONT> Stock Option, an Incentive Stock Option or either or both of them. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.26 &#147;Optionee&#148; means a person to whom an Option has been granted under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.27 &#147;Other Share Award&#148; means an Award of Shares granted pursuant to Section&nbsp;10. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.28 &#147;Parent&#148; means any corporation which is a parent corporation within the meaning of Section&nbsp;424(e) of the Code with respect
to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.29 &#147;Performance Award&#148; means an Award of Performance Units, Performance Shares or either or both of them.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.30 &#147;Performance Cycle&#148; means the time period specified by the Committee at the
time a Performance Award is granted during which the performance of the Company, a Subsidiary or a Division will be measured. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.31
&#147;Performance Objectives&#148; has the meaning set forth in Section&nbsp;9. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.32 &#147;Performance Shares&#148; means Shares issued
to an Eligible Individual under Section&nbsp;9. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.33 &#147;Performance Units&#148; means performance units granted to an Eligible
Individual under Section&nbsp;9. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.34 &#147;Plan&#148; means this Community Health Systems, Inc. 2009 Stock Option and Award Plan, as
amended and restated from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.35 &#147;Restricted Stock&#148; means an Award of Shares issued to an Eligible Individual
pursuant to Section&nbsp;8.1. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.36 &#147;Restricted Stock Units&#148; means an Award of restricted stock units granted to an Eligible
Individual under Section&nbsp;8.2 representing a number of hypothetical Shares (or the Fair Market Value thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.37
&#147;Shares&#148; means shares of the Common Stock of the Company, par value $.01 per share, and any other securities into which such shares are changed or for which such shares are exchanged. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.38 &#147;Stock Appreciation Right&#148; means a right to receive all or some portion of the increase in the value of a Share as provided in
Section&nbsp;7 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.39 &#147;Subsidiary&#148; means (i)&nbsp;except as provided in subsection (ii)&nbsp;below, any corporation which
is a subsidiary corporation within the meaning of Section&nbsp;424(f) of the Code with respect to the Company, and (ii)&nbsp;in relation to the eligibility to receive Options or Awards other than Incentive Stock Options and continued employment for
purposes of Options and Awards (unless the Committee determines otherwise), any entity, whether or not incorporated, in which the Company directly or indirectly owns 50% or more of the outstanding equity or other ownership interests. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.40 <FONT STYLE="white-space:nowrap">&#147;Ten-Percent</FONT> Stockholder&#148; means an Eligible Individual, who, at the time an Incentive
Stock Option is to be granted to him or her, owns (within the meaning of Section&nbsp;422(b)(6) of the Code) stock possessing more than ten percent (10%)&nbsp;of the total combined voting power of all classes of stock of the Company, a Parent or a
Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. Administration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1
<U>Committee</U>. The Plan shall be administered by the Committee, which shall hold meetings at such times as may be necessary for the proper administration of the Plan. The Committee shall keep minutes of its meetings. If the Committee consists of
more than one (1)&nbsp;member, a quorum shall consist of not fewer than two (2)&nbsp;members of the Committee and a majority of a quorum may authorize any action. Any decision or determination reduced to writing and signed by all of the members of
the Committee shall be as fully effective as if approved at a meeting duly called and held. The Committee shall consist of at least one (1)&nbsp;Director and may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consist of the entire Board; provided, however, that with respect to any Option or Award granted to an Eligible Individual who is subject to Section&nbsp;16 of the Exchange Act, the Committee
shall consist of at least two (2)&nbsp;Directors each of whom shall be a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the
Exchange Act. For purposes of the preceding sentence, if any member of the Committee fails to qualify as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director (within the meaning of the preceding sentence), but recuses himself or herself
or abstains from voting with respect to a particular action taken by the Committee, then the Committee, with respect to that action, shall be deemed to consist only of the members of the Committee who have not recused themselves or abstained from
voting. Subject to applicable law, the Committee may delegate its authority under the Plan to any other person or persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>No
Liability</U>. No member of the Committee shall be liable for any action, failure to act, determination or interpretation made in good faith with respect to this Plan or any transaction hereunder. The Company hereby agrees to indemnify each member
of the Committee for all costs and expenses and, to the extent permitted by applicable law, any liability incurred in connection with defending against, responding to, negotiating for the settlement of or otherwise dealing with any claim, cause of
action or dispute of any kind arising in connection with any actions in administering this Plan or in authorizing or denying authorization to any transaction hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Committee Powers</U>. Subject to the express terms and conditions set forth herein, the Committee shall have the power from time to
time to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) determine those Eligible Individuals to whom Options shall be granted under the Plan and the number of such Options to be
granted, prescribe the terms and conditions (which need not be identical) of each such Option, including the exercise price per Share, the vesting schedule and the duration of each Option, and make any amendment or modification to any Option
Agreement consistent with the terms of the Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) select those Eligible Individuals to whom Awards shall be granted under the Plan,
determine the number of Shares in respect of which each Award is granted, the terms and conditions (which need not be identical) of each such Award, and make any amendment or modification to any Award Agreement consistent with the terms of the Plan;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) construe and interpret the Plan and the Options and Awards granted hereunder, establish, amend and revoke rules and regulations for
the administration of the Plan, including, but not limited to, correcting any defect or supplying any omission, or reconciling any inconsistency in the Plan or in any Agreement, in the manner and to the extent it shall deem necessary or advisable,
including so that the Plan and the operation of the Plan comply with Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act, the Code to the extent applicable and other applicable law, and otherwise make the Plan fully effective.
All decisions and determinations by the Committee in the exercise of this power shall be final, binding and conclusive upon the Company, its Subsidiaries, the Optionees and Grantees, and all other persons having any interest therein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) determine the duration and purposes for leaves of absence which may be granted to an Optionee or Grantee on an individual basis without
constituting a termination of employment or service for purposes of the Plan; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) exercise its discretion with respect to the powers and
rights granted to it as set forth in the Plan; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) generally, exercise such powers and perform such acts as are deemed necessary or
advisable to promote the best interests of the Company with respect to the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 Delegation. The Committee may delegate to one or
more officers of the Company the authority to grant Options or Awards to Eligible Individuals (other than to himself or herself) and/or determine the number of Shares subject to each Option or Award (by resolution that specifies the total number of
Shares subject to the Options or Awards that may be awarded by the officer and the terms of any such Options or Awards, including the exercise price), provided that such delegation is made in accordance with the Delaware General Corporation Law and
any other applicable legal requirements, and such Options or Awards are not made to executive officers of the Company covered by Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. Shares Subject to the Plan; Grant Limitations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Shares Subject to the Plan</U><I>. </I>The maximum number of Shares that may be made the subject of Options and Awards granted under
the Plan is the sum of: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) 7,500,000 Shares added to the Plan as a result of the amendment and restatement contemplated hereby effective
on the Restatement Effective Date; plus </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) 1,539,421 Shares remaining in the Plan as of March&nbsp;1, 2023 (after giving effect to the
grant of Awards as part of the Company&#146;s annual equity grant process which was approved by the Committee on February&nbsp;15, 2023, which Awards had a grant date of March&nbsp;1, 2023); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">for a total of 9,039,421 Shares, less any Shares subject to Options or Awards granted after March&nbsp;1, 2023 (the &#147;Share Reserve&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Company shall reserve for the purposes of the Plan, out of its authorized but unissued Shares or out of Shares held in the Company&#146;s
treasury, or partly out of each, such number of Shares as shall be determined by the Board. In addition, for purposes of clarity, the Share Reserve is a limit on the number of Shares that may be issued pursuant to Awards under this Plan, and does
not limit the granting of Awards, except that the Company will keep available at all times the number of Shares reasonably required to satisfy the Company&#146;s obligation to issue Shares pursuant to Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Grant Limitations</U>. The following grant limitations shall apply when making Awards pursuant to the Plan: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The maximum grant date fair value of all Awards granted during any calendar year to a single
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director for service as a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director shall not exceed $800,000; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In no event shall more than an aggregate of 2,000,000 Shares be issued upon the exercise of Incentive Stock Options granted under the
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Fungible Plan Design; Substitute Awards</U>. Upon the grant of an Option or an Award, the Share Reserve shall be reduced as
follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In connection with the grant of an Option or an Award, the Share Reserve shall be
reduced by the number of Shares (determined pursuant to Section&nbsp;4.3(c)) in respect of which such Option or Award is granted or denominated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Stock Appreciation Rights to be settled in Shares shall be counted in full against the Share Reserve, regardless of the number of Shares
issued upon settlement of the Stock Appreciation Right. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding the foregoing, Awards granted in the form of Restricted Stock
(including Restricted Stock Units), Share-settled Performance Awards and Other Share Awards that are granted as &#147;full value awards&#148; on and after the Restatement Effective Date (as defined below) shall reduce the Share Reserve by 1.20
Shares for each Share subject to such an Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, Awards may be assumed or granted in connection with or following a merger
or acquisition involving the Company or any of its Subsidiaries to the extent permitted by Section&nbsp;303A.08 of the NYSE Listed Company Manual (or any successor provision thereof) (any such Awards, &#147;Substitute Awards&#148;), and such
Substitute Awards will not reduce the Share Reserve. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Shares Returned to the Plan</U>. Whenever any outstanding Option or Award or
portion thereof expires, is canceled, is forfeited, is settled in cash or is otherwise terminated for any reason without having been exercised or Shares having been issued in respect of the Option or Award (or such portion thereof to which the
expiration, forfeiture, cash settlement or other termination occurs), the Shares subject to the expired, canceled, forfeited, cash-settled or otherwise terminated portion of the Option or Award may again be the subject of Options or Awards granted
hereunder for purposes of the Share Reserve. With regard to Awards referenced in Section&nbsp;4.3(c), for each Share subject to an Award that is cancelled, forfeited, settled in cash or other otherwise terminated on and after the Restatement
Effective Date as provided in the foregoing sentence (irrespective of whether any such Awards were granted on or after, or prior to, the Restatement Effective Date), 1.20 Shares may again be the subject of Options or Awards under the Plan for
purposes of the Share Reserve. Notwithstanding the foregoing, the following events <U>shall not</U> result in any increase in the Share Reserve: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Withholding of Shares to pay Taxes on any Option or Award, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The excess of the number of Shares subject to any Share-settled Stock Appreciation Rights over the number of Shares actually issued in
settlement thereof, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Tendering of Shares for payment of Option exercise prices or Withholding Taxes (i.e., net settlement of Shares),
and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Any Company purchase of Shares on the open market as a result of Option exercises. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <U>Minimum Vesting Period</U>. No portion of any Option or Award under this Plan will vest prior to one year from the date of grant;
provided, however, that this minimum vesting requirement will not apply to (i)&nbsp;any vesting in connection with any death, Disability, termination of employment or service without Cause or for Good Reason, or a Change in Control, or (ii)&nbsp;any
Options or Awards granted up to a maximum of five percent (5%) of the Share Reserve. For purposes of this Section&nbsp;4.5, any Option or Award made to a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director with a vesting period at least
equal to the period from the annual stockholders&#146; meeting at which the Option or Award is granted to the next annual stockholders&#146; meeting (provided that such annual meetings are at least fifty (50)&nbsp;weeks apart) shall be considered to
have a vesting period of at least one (1)&nbsp;year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. Option Grants for Eligible Individuals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Authority of Committee</U>. Subject to other provisions of the Plan, the Committee shall have full and final authority to select those
Eligible Individuals who will receive Options, and the terms and conditions of the grant to such Eligible Individuals shall be set forth in an Agreement. Incentive Stock Options may be granted only to Eligible Individuals who are employees of the
Company or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Exercise Price</U>. The purchase price for Shares subject to an Option, or the manner in which the
exercise price of an Option is to be determined shall be determined by the Committee and set forth in the Agreement; <I>provided</I>, <I>however</I>, that the exercise price per Share under each Option shall not be less than 100% of the Fair Market
Value of a Share on the date the Option is granted (110% in the case of an Incentive Stock Option granted to a <FONT STYLE="white-space:nowrap">Ten-Percent</FONT> Stockholder). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>Maximum Duration</U>. Options granted hereunder shall be for such term as the Committee shall determine, provided that an Option shall
not be exercisable after the expiration of ten (10)&nbsp;years from the date it is granted (five (5)&nbsp;years in the case of an Incentive Stock Option granted to a <FONT STYLE="white-space:nowrap">Ten-Percent</FONT> Stockholder); provided further,
that unless the Committee provides otherwise, an Option (other than an Incentive Stock Option) shall, upon the death of an Optionee prior to the expiration of the Option, be exercisable for up to one (1)&nbsp;year following the date of such
Optionee&#146;s death even if such period extends beyond ten (10)&nbsp;years from the date the Option was granted. The Committee may, subsequent to the grant of any Option, extend the term thereof, but in no event shall the term be extended to a
date later than the latest date upon which the Option could have expired by its original terms under any circumstances (or, if earlier, the 10th anniversary of the original date of grant of the Option). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Vesting</U>. Subject to Section&nbsp;5.10, each Option shall become exercisable in such installments (which need not be equal) and at
such times as may be designated by the Committee and set forth in the Agreement. To the extent not exercised, installments shall accumulate and be exercisable, in whole or in part, at any time after becoming exercisable, but not later than the date
the Option expires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>Deferred Delivery of Option Shares</U>. Subject to Section&nbsp;18.6, the Committee may permit Optionees to
elect to defer the issuance of Shares upon the exercise of one or more <FONT STYLE="white-space:nowrap">Non-qualified</FONT> Stock Options granted pursuant to the Plan. The terms and conditions of such deferral shall be determined at the time of the
grant of the Option or thereafter and shall be set forth in the Agreement evidencing the Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <U>Limitations on Incentive Stock
Options.</U> To the extent that the aggregate Fair Market Value (determined as of the date of the grant) of Shares with respect to which Incentive Stock Options granted under the Plan and &#147;incentive stock options&#148; (within the meaning of
Section&nbsp;422 of the Code) granted under all other plans of the Company or its Subsidiaries (in either case determined without regard to this Section&nbsp;5.6) are exercisable by an Optionee for the first time during any calendar year exceeds
$100,000, such Incentive Stock Options shall be treated as <FONT STYLE="white-space:nowrap">Non-qualified</FONT> Stock Options. In applying the limitation in the preceding sentence in the case of multiple Option grants, Options which were intended
to be Incentive Stock Options shall be treated as <FONT STYLE="white-space:nowrap">Non-qualified</FONT> Stock Options according to the order in which they were granted such that the most recently granted Options are first treated as <FONT
STYLE="white-space:nowrap">Non-qualified</FONT> Stock Options. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <U><FONT STYLE="white-space:nowrap">Non-Transferability</FONT></U>. No Option shall be
transferable by the Optionee otherwise than by will or by the laws of descent and distribution or, in the case of an Option other than an Incentive Stock Option, pursuant to a domestic relations order (within the meaning of Rule <FONT
STYLE="white-space:nowrap">16a-12</FONT> promulgated under the Exchange Act), and an Option shall be exercisable during the lifetime of such Optionee only by the Optionee or his or her guardian or legal representative. Notwithstanding the foregoing,
the Committee may set forth in the Agreement evidencing an Option (other than an Incentive Stock Option), at the time of grant or thereafter, that the Option may be transferred to members of the Optionee&#146;s immediate family, to trusts solely for
the benefit of such immediate family members and to partnerships in which such family members and/or trusts are the only partners, and for purposes of this Plan, a transferee of an Option shall be deemed to be the Optionee. For this purpose,
immediate family means the Optionee&#146;s spouse, parents, children, stepchildren and grandchildren and the spouses of such parents, children, stepchildren and grandchildren. The terms of an Option shall be final, binding and conclusive upon the
beneficiaries, executors, administrators, heirs and successors of the Optionee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8 <U>Method of Exercise</U>. The exercise of an Option
shall be made only by a written notice delivered in person or by mail, or by such other means acceptable to the Committee and communicated to an Optionee, to the Secretary of the Company at the Company&#146;s principal executive office, specifying
the number of Options to be exercised and, to the extent applicable, accompanied by payment therefor and otherwise in accordance with the Agreement pursuant to which the Option was granted; <I>provided, however</I>, that Options may not be exercised
by an Optionee following a hardship distribution to the Optionee to the extent such exercise is prohibited under the Community Health Systems, Inc. 401(k) Plan. The exercise price for any Shares purchased pursuant to the exercise of an Option shall
be paid in either of the following forms (or any combination thereof): (a)&nbsp;cash or (b)&nbsp;the transfer, either actually or by attestation, to the Company of Shares owned by the Optionee prior to the exercise of the Option, such transfer to be
upon such terms and conditions as determined by the Committee or (c)&nbsp;a combination of cash and the transfer of Shares; <I>provided, however</I>, that the Committee may determine that the exercise price shall be paid only in cash. In addition,
subject to applicable securities laws, Options may be exercised pursuant to such other cashless exercise procedures that are, from time to time, deemed acceptable by the Committee. Any Shares transferred to the Company as payment of the exercise
price under an Option shall be valued at their Fair Market Value on the day of exercise of such Option. If requested by the Committee, the Optionee shall deliver the Agreement evidencing the Option to the Secretary of the Company who shall endorse
thereon a notation of such exercise and return such Agreement to the Optionee. No fractional Shares (or cash in lieu thereof) shall be issued upon exercise of an Option and the number of Shares that may be purchased upon exercise shall be rounded to
the nearest number of whole Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9 <U>Rights of Optionees</U>. No Optionee shall be deemed for any purpose to be the owner of any
Shares subject to any Option unless and until (a)&nbsp;the Option shall have been exercised pursuant to the terms thereof, (b)&nbsp;the Company shall have issued and delivered Shares to the Optionee, and (c)&nbsp;the Optionee&#146;s name shall have
been entered as a stockholder of record on the books of the Company or otherwise evidenced by a &#147;book entry&#148; (<I>i.e</I>., a computerized or manual entry) in the records of the Company or its designated agent. Thereupon, the Optionee shall
have full voting, dividend and other ownership rights with respect to such Shares, subject to such terms and conditions as may be set forth in the applicable Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10 <U>Effect of Change in Control</U>. Section&nbsp;13(b) shall control the treatment of
any Options outstanding at the time of a Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Limitations on Repricing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything in the Plan to the contrary, except as permitted or required by the provisions of Sections 12 or 13 hereof, neither
the Board nor the Committee shall have the power to (i)&nbsp;lower the Option Price of an Option after it is granted, (ii)&nbsp;lower the Grant Price of a Stock Appreciation Right after it is granted, (iii)&nbsp;cancel an Option when the exercise
price thereof exceeds the Fair Market Value of the underlying Shares in exchange for cash or another Award or grant substitute Options with a lower exercise price than the cancelled Options, (iv)&nbsp;cancel a Stock Appreciation Right when the Grant
Price exceeds the Fair Market Value of the underlying Shares in exchange for cash or another Award, or grant substitute Stock Appreciation Rights with a lower Grant Price than the cancelled Award, or (v)&nbsp;take any other action with respect to an
Option or Stock Appreciation Right that would be treated as a repricing under the rules and regulations of the principal securities exchange on which the Shares are traded, in each case without the approval of the Company&#146;s stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. Stock Appreciation Rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Committee
may in its discretion, either alone or in connection with the grant of an Option, grant Stock Appreciation Rights in accordance with the Plan and such other terms and conditions as shall be set forth in an Agreement. If granted in connection with an
Option, a Stock Appreciation Right shall cover the same Shares covered by the Option (or such lesser number of Shares as the Committee may determine) and shall, except as provided in this Section&nbsp;7, be subject to the same terms and conditions
as the related Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <U>Time of Grant</U>. A Stock Appreciation Right may be granted (a)&nbsp;at any time if unrelated to an
Option, or (b)&nbsp;if related to an Option, either at the time of grant or at any time thereafter during the term of the Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2
<U>Stock Appreciation Right Related to an Option</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Exercise</U>. A Stock Appreciation Right granted in connection with an
Option shall be exercisable at such time or times and only to the extent that the related Option is exercisable, and will not be transferable except to the extent the related Option may be transferable. A Stock Appreciation Right granted in
connection with an Incentive Stock Option shall be exercisable only if the Fair Market Value of a Share on the date of exercise exceeds the exercise price specified in the related Incentive Stock Option Agreement. In no event shall a Stock
Appreciation Right related to an Option have a term of greater than ten (10)&nbsp;years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Amount Payable</U>. Upon the exercise of
a Stock Appreciation Right related to an Option, the Grantee shall be entitled to receive an amount determined by multiplying (i)&nbsp;the excess of the Fair Market Value of a Share on the date of exercise of such Stock Appreciation Right over the
per Share exercise price under the related Option, by (ii)&nbsp;the number of Shares as to which such Stock Appreciation Right is being exercised. Notwithstanding the foregoing, the Committee may limit in any manner the amount payable with respect
to any Stock Appreciation Right by including such a limit in the Agreement evidencing the Stock Appreciation Right at the time it is granted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Treatment of Related Options and Stock Appreciation Rights upon Exercise</U>. Upon
the exercise of a Stock Appreciation Right related to an Option, the Option shall be canceled to the extent of the number of Shares as to which the Stock Appreciation Right is exercised, and upon the exercise of an Option related to a Stock
Appreciation Right, the Stock Appreciation Right shall be canceled to the extent of the number of Shares as to which the Option is exercised or surrendered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <U>Stock Appreciation Right Unrelated to an Option</U>. The Committee may grant Stock Appreciation Rights unrelated to Options to Eligible
Individuals. Stock Appreciation Rights unrelated to Options shall contain such terms and conditions as to exercisability (subject to Section&nbsp;7.7), vesting and duration as the Committee shall determine, but in no event shall any Stock
Appreciation Right have a term of greater than ten (10)&nbsp;years. The Committee shall establish the Grant Price at the time each Stock Appreciation Right unrelated to an Option is granted, which shall not be less than the Fair Market Value of a
Share on the date the Stock Appreciation Right is granted. Upon exercise of a Stock Appreciation Right unrelated to an Option, the Grantee shall be entitled to receive an amount determined by multiplying (a)&nbsp;the excess of the Fair Market Value
of a Share on the date of exercise of such Stock Appreciation Right over the Grant Price of the Stock Appreciation Right, by (b)&nbsp;the number of Shares as to which the Stock Appreciation Right is being exercised. Notwithstanding the foregoing,
the Committee may limit in any manner the amount payable with respect to any Stock Appreciation Right by including such a limit in the Agreement evidencing the Stock Appreciation Right at the time it is granted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <U><FONT STYLE="white-space:nowrap">Non-Transferability</FONT></U>. No Stock Appreciation Right shall be transferable by the Grantee
otherwise than by will or by the laws of descent and distribution or pursuant to a domestic relations order (within the meaning of Rule <FONT STYLE="white-space:nowrap">16a-12</FONT> promulgated under the Exchange Act), and such Stock Appreciation
Right shall be exercisable during the lifetime of such Grantee only by the Grantee or his or her guardian or legal representative. The terms of such Stock Appreciation Right shall be final, binding and conclusive upon the beneficiaries, executors,
administrators, heirs and successors of the Grantee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5 <U>Method of Exercise</U>. Stock Appreciation Rights shall be exercised by a
Grantee only by a written notice delivered in person or by mail, or by such other means acceptable to the Committee and communicated to the Grantee, to the Secretary of the Company at the Company&#146;s principal executive office, specifying the
number of Shares with respect to which the Stock Appreciation Right is being exercised. If requested by the Committee, the Grantee shall deliver the Agreement evidencing the Stock Appreciation Right being exercised and the Agreement evidencing any
related Option to the Secretary of the Company who shall endorse thereon a notation of such exercise and return such Agreement to the Grantee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.6 <U>Form of Payment</U>. Payment of the amount determined under Sections 7.2(b) or 7.3 may be made in the discretion of the Committee
solely in whole Shares in a number determined at their Fair Market Value on the date of exercise of the Stock Appreciation Right, or solely in cash, or in a combination of cash and Shares. If the Committee decides to make full payment in Shares and
the amount payable results in a fractional Share, payment for the fractional Share will be made in cash. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.7 <U>Effect of Change in Control</U>. Section&nbsp;13(b) shall control the treatment of
any Stock Appreciation Rights outstanding at the time of a Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Restricted Stock and Restricted Stock Units. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1 <U>Restricted Stock</U>. The Committee may grant Awards of Restricted Stock to Eligible Individuals, which shall be evidenced by an
Agreement between the Company and the Grantee. Each Agreement shall contain such restrictions, terms and conditions as the Committee may, in its discretion, determine and (without limiting the generality of the foregoing) such Agreements may require
that an appropriate legend be placed on Share certificates. The Committee may provide that a Grantee&#146;s ownership of Restricted Stock prior to the lapse of any transfer restrictions or any other applicable restrictions shall, in lieu of such
certificates, be evidenced by a &#147;book entry&#148; (<I>i.e</I>., a computerized or manual entry) in the records of the Company or its designated agent in the name of the Grantee who has received such Award, and confirmation and account
statements sent to the Grantee with respect to such book entry Shares may bear the restrictive legend referenced in the preceding sentence. Such records of the Company or such agent shall, absent manifest error, be binding on all Grantees who
receive Restricted Stock Awards evidenced in such manner. Awards of Restricted Stock shall be subject to the terms and provisions set forth below in this Section&nbsp;8.1. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Rights of Grantee</U>. Subject to the foregoing provisions concerning book entry issuance, Shares of Restricted Stock granted pursuant
to an Award hereunder shall be issued in the name of the Grantee as soon as reasonably practicable after the Award is granted provided that, to the extent required in the Agreement and/or by the Committee, the Grantee has executed an Agreement
evidencing the Award and followed such other procedures and/or executed such other documentation as may be required by the Agreement and/or the Committee, and in each case, including by electronic execution. If a Grantee shall fail to so execute the
Agreement evidencing a Restricted Stock Award and/or shall fail to follow any such procedures or execute any such other documentation, the Award shall be null and void to the extent provided by the Agreement and/or the Committee. Unless the
Committee determines otherwise and as set forth in the Agreement, subject to Section&nbsp;8.1(d) below, the Grantee shall have all of the rights of a stockholder with respect to such Shares, including the right to vote the Shares and to receive all
dividends or other distributions paid or made with respect to the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
<U><FONT STYLE="white-space:nowrap">Non-Transferability</FONT></U>. Until all restrictions upon the Shares of Restricted Stock awarded to a Grantee shall have lapsed in the manner set forth in Section&nbsp;8.1(c), such Shares shall not be sold,
transferred or otherwise disposed of and shall not be pledged or otherwise hypothecated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Lapse of Restrictions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Generally</U>. Restrictions upon Shares of Restricted Stock awarded hereunder shall lapse at such time or times and on
such terms and conditions as the Committee may determine. The Agreement evidencing the Award shall set forth any such restrictions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) <U>Effect of Change in Control</U>. Section&nbsp;13(b) shall control the treatment of any Shares of Restricted Stock then
outstanding in the event of a Change in Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Treatment of Dividends</U>. At the time an Award of Shares of Restricted Stock is
granted, the Committee may, in its discretion, determine that the payment to the Grantee of dividends, or a specified portion thereof, declared or paid on such Shares by the Company shall be (i)&nbsp;deferred until the lapsing of the restrictions
imposed upon such Shares and (ii)&nbsp;held by the Company for the account of the Grantee until such time. In the event that dividends are to be deferred, the Committee shall determine whether such dividends are to be reinvested in Shares (which
shall be held as additional Shares of Restricted Stock) or held in cash. If deferred dividends are to be held in cash, there may be credited at the end of each year (or portion thereof) interest on the amount of the account at the beginning of the
year at a rate per annum as the Committee, in its discretion, may determine. Payment of deferred dividends in respect of Shares of Restricted Stock (whether held in cash or as additional Shares of Restricted Stock), together with interest accrued
thereon, if any, shall be made upon the lapsing of restrictions imposed on the Shares in respect of which the deferred dividends were paid, and any dividends deferred (together with any interest accrued thereon) in respect of any Shares of
Restricted Stock shall be forfeited upon the forfeiture of such Shares. For the avoidance of doubt, if deferred dividends are not paid with respect to a Share of Restricted Stock, no dividends shall be paid on such Share of Restricted Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Delivery of Shares</U>. Upon the lapse of the restrictions on Shares of Restricted Stock, the Company shall cause a stock certificate
to be delivered to the Grantee with respect to such Shares, free of all restrictions hereunder (or, in the case of book entry Shares, such restrictions and legend shall be removed from the confirmation and account statements delivered to the Grantee
or the Grantee&#146;s beneficiary or estate, as the case may be, in book-entry form). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <U>Restricted Stock Units</U>. The Committee
may grant to Eligible Individuals Awards of Restricted Stock Units, which shall be evidenced by an Agreement between the Company and the Grantee, provided that, to the extent required in the Agreement and/or by the Committee, any such Grantee has
executed an Agreement evidencing the Award and followed such other procedures and/or executed such other documentation as may be required by the Agreement and/or the Committee, and in each case, including by electronic execution. Each such Agreement
shall contain such restrictions, terms and conditions as the Committee may determine. Awards of Restricted Stock Units shall be subject to the terms and provisions set forth below in this Section&nbsp;8.2. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Payment of Awards</U>. Each Restricted Stock Unit shall represent a Grantee&#146;s right to receive a payment upon vesting of the
Restricted Stock Unit or on any later date specified by the Committee equal to the Fair Market Value of a Share as of the date the Restricted Stock Unit was granted, the vesting date or such other date as determined by the Committee at the time the
Restricted Stock Unit was granted. The Committee may, at the time a Restricted Stock Unit is granted, provide a limitation on the amount payable in respect of each Restricted Stock Unit and may provide for Dividend Equivalent Rights with respect to
such Award; provided, that no Dividend Equivalent Rights shall be paid except to the extent the underlying Restricted Stock Unit is paid or settled. The Committee may provide for the settlement of Restricted Stock Units in cash or with Shares having
a Fair Market Value equal to the payment to which the Grantee has become entitled. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Effect of Change in Control</U>.
Section&nbsp;13(b) shall control the treatment of any Restricted Stock Units then outstanding in the event of a Change in Control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. Performance Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <U>Performance Units</U>. The Committee, in its discretion, may grant Awards of Performance Units to Eligible Individuals, the terms and
conditions of which shall be set forth in an Agreement between the Company and the Grantee, provided that, to the extent required in the Agreement and/or by the Committee, any such Grantee has executed an Agreement evidencing the Award and followed
such other procedures and/or executed such other documentation as may be required by the Agreement and/or the Committee, and in each case, including by electronic execution. Contingent upon the attainment of specified Performance Objectives within
the Performance Cycle, Performance Units represent the right to receive payment as provided in Section&nbsp;9.1(b) of (i)&nbsp;the Fair Market Value of a Share on the date the Performance Unit was granted, the date the Performance Unit became vested
or any other date specified by the Committee or (ii)&nbsp;a percentage (which may be more than 100%) of the amount described in clause (i)&nbsp;depending on the level of Performance Objective attainment; <I>provided, however</I>, that the Committee
may at the time a Performance Unit is granted specify a maximum amount payable in respect of a vested Performance Unit. Each Agreement shall specify the number of Performance Units to which it relates, the Performance Objectives which must be
satisfied in order for the Performance Units to vest and the Performance Cycle within which such Performance Objectives must be satisfied. At the time a Performance Unit is granted, the Committee may provide for Dividend Equivalent Rights with
respect to such Award; provided, that no Dividend Equivalent Rights shall be paid except to the extent the underlying Performance Unit is paid or settled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Vesting and Forfeiture</U>. Subject to Section&nbsp;9.4, a Grantee shall become vested with respect to the Performance Units to the
extent that the Performance Objectives set forth in the Agreement are satisfied for the Performance Cycle or as otherwise provided in any Agreement with respect thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Payment of Awards</U>. Payment to Grantees in respect of vested Performance Units shall be made as soon as practicable after the last
day of the Performance Cycle to which such Award relates unless the Agreement evidencing the Award provides for the deferral of payment (or an election therefor), in which event the terms and conditions of the deferral shall be set forth in the
Agreement. Subject to Section&nbsp;9.4, such payments may be made entirely in Shares valued at their Fair Market Value, entirely in cash, or in such combination of Shares and cash as the Committee in its discretion shall determine at any time prior
to such payment, <I>provided, however</I>, that, subject to Section&nbsp;18.6, if the Committee in its discretion at or after grant determines to make such payment entirely or partially in Shares of Restricted Stock, the Committee must determine the
extent to which such payment will be in Shares of Restricted Stock and the terms of such Restricted Stock at the time the Award is granted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <U>Performance Shares</U>. The Committee, in its discretion, may grant Awards of Performance Shares to Eligible Individuals, the terms and
conditions of which shall be set forth in an Agreement between the Company and the Grantee, provided that, to the extent required in the Agreement and/or by the Committee, any such Grantee has executed an Agreement evidencing the Award and followed
such other procedures and/or executed such other documentation as may be required by the Agreement and/or the Committee, and in each case, including by electronic execution. Each Agreement may require that an appropriate legend be placed on Share
certificates. Awards of Performance Shares shall be subject to the following terms and provisions: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Rights of Grantee</U>. The Committee shall provide at the time an Award of
Performance Shares is made the time or times at which the actual Shares represented by such Award shall be issued in the name of the Grantee; <I>provided, however</I>, that, to the extent required in the Agreement and/or by the Committee, no
Performance Shares shall be issued until the Grantee has executed an Agreement evidencing the Award and followed such other procedures as may be required by the Agreement and/or the Committee, and in each case, including by electronic execution. If
a Grantee shall fail to so execute the Agreement evidencing an Award of Performance Shares and/or shall fail to follow any such procedures and/or execute such other documentation, the Award shall be null and void to the extent provided by the
Agreement and/or the Committee. The Committee may, in its discretion, provide that Performance Shares shall be evidenced by the book entry procedures set forth in Section&nbsp;8.1. Except as restricted by the terms of the Agreement, subject to
Section&nbsp;9.2(d) below, the Grantee shall have, in the discretion of the Committee, all of the rights of a stockholder with respect to such Shares, including the right to vote the Shares and to receive all dividends or other distributions paid or
made with respect to the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U><FONT STYLE="white-space:nowrap">Non-Transferability</FONT></U>. Until any restrictions upon the
Performance Shares awarded to a Grantee shall have lapsed in the manner set forth in Section&nbsp;9.2(c) or 9.4, such Performance Shares shall not be sold, transferred or otherwise disposed of and shall not be pledged or otherwise hypothecated, nor
shall they be delivered to the Grantee. The Committee may also impose such other restrictions and conditions on the Performance Shares as it deems appropriate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Lapse of Restrictions</U>. Subject to Section&nbsp;9.4, restrictions upon Performance Shares awarded hereunder shall lapse and such
Performance Shares shall become vested at such time or times and on such terms, conditions and satisfaction of Performance Objectives as the Committee may, in its discretion, determine at the time an Award is granted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <U>Treatment of Dividends</U>. The payment to the Grantee of dividends, or a specified portion thereof, declared or paid on Shares
represented by an Award of Performance Shares which have been issued by the Company to the Grantee shall be (i)&nbsp;deferred until the lapse of the restrictions imposed upon such Performance Shares and (ii)&nbsp;held by the Company or its agent for
the account of the Grantee until such time. The Committee shall determine whether such dividends are to be reinvested in shares of Stock (which shall be held as additional Performance Shares) or held in cash. If deferred dividends are to be held in
cash, there may be credited at the end of each year (or portion thereof) interest on the amount of the account at the beginning of the year at a rate per annum as the Committee, in its discretion, may determine. Payment of deferred dividends in
respect of Performance Shares (whether held in cash or in additional Performance Shares), together with interest accrued thereon, if any, shall be made upon the lapsing of restrictions imposed on the Performance Shares in respect of which the
deferred dividends were paid, and any dividends deferred (together with any interest accrued thereon) in respect of any Performance Shares shall be forfeited upon the forfeiture of such Performance Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <U>Delivery of Shares</U>. Upon the lapse of the restrictions on Performance Shares awarded hereunder, the Committee shall cause a stock
certificate to be delivered to the Grantee with respect to such Shares, free of all restrictions hereunder, or in the case of book entry Shares, such restrictions and legend shall be removed from the confirmation and account statements delivered to
the Grantee or the Grantee&#146;s beneficiary or estate, as the case may be. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 Performance Objectives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Establishment</U>. Performance Objectives for Performance Awards may be expressed in terms of (i)&nbsp;earnings per Share,
(ii)&nbsp;net revenue, (iii)&nbsp;EBITDA or adjusted EBITDA, (iv)&nbsp;Share price, <FONT STYLE="white-space:nowrap">(v)&nbsp;pre-tax</FONT> profits, (vi)&nbsp;net earnings, (vii)&nbsp;return on equity or assets, (viii)&nbsp;operating income,
(ix)&nbsp;EBITDA or adjusted EBITDA margin, (x)&nbsp;EBITDA or adjusted EBITDA margin improvement, (xi)&nbsp;bad debt expense, (xii)&nbsp;cash receipts, (xiii)&nbsp;uncompensated care expense, (xiv)&nbsp;days in net revenue in net patient accounts
receivable, (xv)&nbsp;gross income, (xvi)&nbsp;net income (before or after taxes), (xvii)&nbsp;cash flow; (xviii)&nbsp;gross profit, (xix)&nbsp;gross profit return on investment, (xx)&nbsp;gross margin return on investment, (xxi)&nbsp;gross margin;
(xxii)&nbsp;operating margin, (xxiii)&nbsp;working capital, (xxiv)&nbsp;earnings before interest and taxes, (xxv)&nbsp;return on capital, (xxvi)&nbsp;return on invested capital, (xxvii)&nbsp;revenue growth, (xxviii)&nbsp;annual recurring revenues,
(xxix)&nbsp;recurring revenues, (xxx)&nbsp;total shareholder return, (xxxi)&nbsp;economic value added, (xxxii)&nbsp;specified objectives with regard to limiting the level of increase in all or a portion of the Company&#146;s bank debt or other
long-term or short-term public or private debt or other similar financial obligations of the Company, which may be calculated net of cash balances and/or other offsets and adjustments as may be established by the Committee in its sole discretion,
(xxxiii)&nbsp;reduction in operating expenses, (xxxiv)&nbsp;same-store financial metrics in relation to any of the foregoing, (xxxv)&nbsp;any combination of the foregoing, (xxxvi)&nbsp;individual performance criteria, or (xxxvii)&nbsp;any other
quantitative or qualitative performance criteria as may be determined by the Committee in its discretion. Performance Objectives may be in respect of the performance of the Company, any of its Subsidiaries, any of its Divisions or any combination
thereof. Performance Objectives may be absolute or relative (to prior performance of the Company or to the performance of one or more other entities or external indices) and may be expressed in terms of a progression within a specified range. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Effect of Certain Events</U>. At the time of the grant of a Performance Award, or at any time thereafter, the Committee may provide for
the manner in which performance will be measured against the Performance Objectives (or may adjust the Performance Objectives) to reflect the impact of specified corporate transactions, accounting or tax law changes, other extraordinary, unusual or
nonrecurring events, and such other matters that the Committee determines is consistent with the intent of the Performance Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4
<U>Effect of Change in Control</U>. Section&nbsp;13(b) shall control the treatment of any Performance Units then outstanding in the event of a Change in Control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <U><FONT STYLE="white-space:nowrap">Non-Transferability</FONT></U>. Until the vesting of Performance Units or the lapse of any
restrictions on Performance Shares, as the case may be, such Performance Units or Performance Shares shall not be sold, transferred or otherwise disposed of and shall not be pledged or otherwise hypothecated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">10. Other Share Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Committee may
grant an Other Share Award to any Eligible Individual, which Other Share Award shall consist of any right that is (i)&nbsp;not an Award described in<U>&nbsp;Sections 5,</U><U>&nbsp;6</U>, 8 or 9 above and (ii)&nbsp;an Award of Shares or an Award
denominated or payable in, valued in whole or in part by reference to, or otherwise based on or related to, Shares, as determined by the Committee to be consistent with the purposes of the Plan. Other Share Awards may be made as additional
compensation for services rendered by the Eligible Individual or may be in lieu of cash or other compensation to which the Eligible Individual is entitled from the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">11. Effect of a Termination of Employment or Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The Agreement evidencing the grant of each Option and each Award shall set forth the terms and conditions applicable to such Option or Award
upon a termination or change in the status of the employment and/or service of the Optionee or Grantee by the Company, a Subsidiary or a Division (including a termination or change by reason of the sale of a Subsidiary or a Division), which shall be
as the Committee may, in its discretion, determine at the time the Option or Award is granted or thereafter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">12. Adjustment Upon Changes in
Capitalization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event of a Change in Capitalization, subject to Section&nbsp;13, the Committee shall conclusively determine
the appropriate adjustments, if any, to (i)&nbsp;the maximum number and class of Shares or other stock or securities with respect to which Options or Awards may be granted under the Plan, (ii)&nbsp;applicable limits with respect to the Shares and
Awards as provided herein, (iii)&nbsp;the number and class of Shares or other stock or securities which are subject to outstanding Options or Awards granted under the Plan and the exercise price therefor, if applicable, and (iv)&nbsp;Performance
Objectives applicable to outstanding Performance Awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Any such adjustment in the Shares or other stock or securities subject to
outstanding Incentive Stock Options (including any adjustments in the exercise price) shall be made in such manner as not to constitute a modification as defined by Section&nbsp;424(h)(3) of the Code and only to the extent permitted by Sections 422
and 424 of the Code. In addition, (a)&nbsp;no adjustment to any Option or Award that is not subject to Section&nbsp;409A of the Code shall be made in a manner that would subject the Option or Award to Section&nbsp;409A of the Code and (b)&nbsp;any
adjustment to an Option or Award that is subject to Section&nbsp;409A of the Code shall be made only in a manner and to the extent permitted by Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If, by reason of a Change in Capitalization, a Grantee of an Award shall be entitled to, or an Optionee shall be entitled to exercise an
Option with respect to, new, additional or different shares of stock or securities of the Company or any other corporation, such new, additional or different shares shall thereupon be subject to all of the conditions, restrictions and performance
criteria which were applicable to the Shares subject to the Award or Option, as the case may be, prior to such Change in Capitalization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">13. Effect of
Certain Transactions; Effect of Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Effect of Certain Transactions.</U> Subject to Section&nbsp;13(b), or as
otherwise provided in an Agreement, in the event of (a)&nbsp;the liquidation or dissolution of the Company or (b)&nbsp;a merger or consolidation of the Company (a &#147;Transaction&#148;), the Plan and the Options and Awards issued hereunder shall
continue in effect in accordance with their respective terms, except that following a Transaction either (i)&nbsp;each outstanding Option or Award shall be treated as provided for in the agreement entered into in connection with the Transaction or
(ii)&nbsp;if not so provided in such agreement, each Optionee and Grantee shall be entitled to receive in respect of each Share subject to any outstanding Options or Awards, as the case may be, upon exercise of any Option or payment or transfer in
respect of any Award, the same number and kind of stock, securities, cash, property or other consideration that each holder of a Share was entitled to receive in the Transaction in respect of a Share; <I>provided, however</I>, that such stock,
securities, cash, property, or other consideration shall remain subject to all of the conditions, restrictions and performance criteria which were applicable to the Options and Awards prior to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such Transaction. For the avoidance of doubt, the Committee may, without the consent of any Optionee or Grantee, provide for the cancellation of outstanding Awards in connection with a
Transaction in exchange for the payment in cash or property equal in value to the Fair Market Value of the Shares underlying such Awards, less, in the case of Options (and Stock Appreciation Rights), the aggregate exercise price (or Grant Price)
thereof; <I>provided</I> that Options with an aggregate exercise price that is equal to or in excess of the aggregate Fair Market Value of the Shares underlying such Options, and Stock Appreciation Rights whose Grant Price is equal to or in excess
of the Fair Market Value of a Share to which such Stock Appreciation Rights relate, may be cancelled in connection with such Transaction without any consideration being paid in respect thereof. The treatment of any Option or Award as provided in
this Section&nbsp;13(a) shall be conclusively presumed to be appropriate for purposes of Section&nbsp;12. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Effect of Change in
Control</U>. Notwithstanding any other provision of the Plan to the contrary, in the event of a Change in Control, the following provisions of this Section&nbsp;13(b) shall apply except to the extent an Agreement provides for a different treatment
(in which case the Agreement shall govern and this Section&nbsp;13(b) shall not be applicable): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) If and to the extent
that outstanding Options or Awards under the Plan (A)&nbsp;are assumed by the successor entity (or affiliate thereto) or continued or (B)&nbsp;are replaced with equity awards that preserve the existing value of the Options or Awards at the time of
the Change in Control and provide for subsequent payout in accordance with a vesting schedule and Performance Objectives, as applicable, that are the same or more favorable to the Grantees than the vesting schedule and Performance Objectives
applicable to the Options or Awards, then all such Options or Awards or such substitutes thereof shall remain outstanding and be governed by their respective terms and the provisions of the Plan, subject to Section&nbsp;13(b)(iv) below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) If and to the extent that outstanding Options or Awards under the Plan are not assumed, continued or replaced in
accordance with Section&nbsp;13(b)(i) above, then upon the Change in Control the following treatment (referred to as <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Change-in-Control</FONT></FONT> Treatment&#148;) shall apply
to such Options or Awards: (A)&nbsp;outstanding Options and Stock Appreciation Rights shall immediately vest and become exercisable; (B)&nbsp;the restrictions and other conditions applicable to outstanding Restricted Shares, Restricted Stock Units
and Stock Awards, including vesting requirements, shall immediately lapse; such Awards shall be free of all restrictions and fully vested; and, with respect to Restricted Stock Units, shall be payable immediately in accordance with their terms or,
if later, as of the earliest permissible date under Code Section&nbsp;409A; and (C)&nbsp;outstanding Performance Awards granted under the Plan shall immediately vest and shall become immediately payable in accordance with their terms as if the
Performance Objectives have been achieved at the target performance level. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) If and to the extent that outstanding
Options or Awards under the Plan are not assumed, continued or replaced in accordance with Section&nbsp;13(b)(i) above, then in connection with the application of the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Treatment set forth in Section&nbsp;13(b)(ii) above, the Board and/or the Committee may, in its sole discretion, provide for cancellation of such
outstanding Awards at the time of the Change in Control in which case a payment of cash, property or a combination thereof shall be made to each such Optionee or Grantee upon the consummation of the Change in Control that is determined by the Board
and/or Committee in its sole discretion and that is at least equal to the excess (if any) of the value of the consideration that would be received in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
such Change in Control by the holders of the Company&#146;s securities relating to such Options or Awards over the exercise or purchase price (if any) for such Options or Awards (except that, in
the case of an Option or Stock Appreciation Right, such payment shall be limited as necessary to prevent the Option or Stock Appreciation Right from being subject to tax under Code Section&nbsp;409A); <I>provided</I> that Options with an aggregate
exercise price that is equal to or in excess of the Fair Market Value of a Share in such Change in Control, and Stock Appreciation Rights whose Grant Price is equal to or in excess of the Fair Market Value of a Share in connection with such Change
in Control, may be cancelled in connection with such Change in Control as may be determined by the Board and/or Committee in its sole discretion without any consideration being paid in respect thereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) If and to the extent that (A)&nbsp;outstanding Options or Awards are assumed, continued or replaced in accordance with
Section&nbsp;13(b)(i) above and (B)&nbsp;a Optionee&#146;s or Grantee&#146;s employment with, or performance of services for, the Company or any of its Subsidiaries or successors is terminated by the Company or such Subsidiary or successor for any
reason other than Cause or by such Optionee or Grantee for Good Reason, in each case, within the <FONT STYLE="white-space:nowrap">two-year</FONT> period commencing on the Change in Control, then, as of the date of such Optionee&#146;s or
Grantee&#146;s termination, the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Change-in-Control</FONT></FONT> Treatment set forth in Section&nbsp;13(b)(ii) above shall apply to all assumed or replaced Options or Awards of such
Optionee or Grantee then outstanding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) Outstanding Options or Stock Appreciation Rights that are assumed, continued or
replaced in accordance with Section&nbsp;13(b)(i) may be exercised by the Optionee or Grantee in accordance with the applicable terms and conditions of such Option or Stock Appreciation Right as set forth in the applicable Agreement or elsewhere;
provided, however, that Options or Stock Appreciation Rights that become exercisable in accordance with Section&nbsp;13(b)(iv) may be exercised until the expiration of the original full term of such Option or Stock Appreciation Right notwithstanding
the other original terms and conditions of such Award, to the extent allowed without such Option or Stock Appreciation Right becoming subject to tax under Code Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">14. Interpretation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Plan is intended
to comply with Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act and the Committee shall interpret and administer the provisions of the Plan or any Agreement in a manner consistent therewith. Any provisions
inconsistent with such Rule shall be inoperative and shall not affect the validity of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) To the extent that any legal
requirement of Section&nbsp;16 of the Exchange Act as set forth in the Plan ceases to be required under Section&nbsp;16 of the Exchange Act, that Plan provision shall cease to apply. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">15. Termination and Amendment of the Plan or Modification of Options and Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.1 <U>Plan Amendment or Termination</U>. The Plan shall terminate on the day preceding the tenth anniversary of the Restatement Effective
Date and no Option or Award may be granted thereafter. The Board may sooner terminate the Plan and the Board, subject to Section&nbsp;6, may at any time and from time to time amend, modify or suspend the Plan; <I>provided, however</I>, that: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) no such amendment, modification, suspension or termination shall impair or materially
and adversely alter any Options or Awards theretofore granted under the Plan, except with the written consent of the applicable Optionee or Grantee, nor shall any amendment, modification, suspension or termination deprive any Optionee or Grantee of
any Shares which he or she may have acquired through or as a result of the Plan; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) to the extent necessary under any applicable
law, regulation or exchange requirement with which the Committee determines it is necessary or desirable for the Company to comply, no amendment shall be effective unless approved by the stockholders of the Company in accordance with any such law,
regulation or exchange requirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15.2 <U>Modification of Options and Awards</U>. No modification of an Option or Award shall
materially and adversely alter or impair any rights or obligations under the Option or Award without the written consent of the Optionee or Grantee, as the case may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">16. <FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The adoption of the Plan by the Board shall not be construed as amending, modifying or rescinding any previously approved incentive
arrangement or as creating any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of stock options otherwise than under the Plan, and such
arrangements may be either applicable generally or only in specific cases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17. Limitation of Liability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">As illustrative of the limitations of liability of the Company, but not intended to be exhaustive thereof, nothing in the Plan shall be
construed to: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) give any person any right to be granted an Option or Award other than at the sole discretion of the Committee; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) give any person any rights whatsoever with respect to Shares except as specifically provided in the Plan; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) limit in any way the right of the Company or any Subsidiary to terminate the employment of any person at any time; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) be evidence of any agreement or understanding, expressed or implied, that the Company will employ any person at any particular rate of
compensation or for any particular period of time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">18. Regulations and Other Approvals; Governing Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.1 Except as to matters of federal law, the Plan and the rights of all persons claiming hereunder shall be construed and determined in
accordance with the laws of the State of Delaware without giving effect to conflicts of laws principles thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.2 The obligation of
the Company to sell or deliver Shares with respect to Options and Awards granted under the Plan shall be subject to all applicable laws, rules and regulations, including all applicable federal and state securities laws, and the obtaining of all such
approvals by governmental agencies as may be deemed necessary or appropriate by the Committee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.3 The Board may make such changes as may be necessary or appropriate to comply with the
rules and regulations of any government authority, or to obtain for Eligible Individuals granted Incentive Stock Options the tax benefits under the applicable provisions of the Code and regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.4 Each Option and Award is subject to the requirement that, if at any time the Committee determines, in its discretion, that the listing,
registration or qualification of Shares issuable pursuant to the Plan is required by any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory body is necessary or desirable as a condition
of, or in connection with, the grant of an Option or Award or the issuance of Shares, no Options or Awards shall be granted or payment made or Shares issued, in whole or in part, unless listing, registration, qualification, consent or approval has
been effected or obtained free of any conditions as acceptable to the Committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.5 Notwithstanding anything contained in the Plan or
any Agreement to the contrary, in the event that the disposition of Shares acquired pursuant to the Plan is not covered by a then current registration statement under the Securities Act of 1933, as amended (the &#147;Securities Act&#148;), and is
not otherwise exempt from such registration, such Shares shall be restricted against transfer to the extent required by the Securities Act and Rule 144 or other regulations thereunder. The Committee may require any individual receiving Shares
pursuant to an Option or Award granted under the Plan, as a condition precedent to receipt of such Shares, to represent and warrant to the Company in writing that the Shares acquired by such individual are acquired without a view to any distribution
thereof and will not be sold or transferred other than pursuant to an effective registration thereof under the Securities Act or pursuant to an exemption applicable under the Securities Act or the rules and regulations promulgated thereunder. The
certificates evidencing any such Shares shall be appropriately amended or have an appropriate legend placed thereon to reflect their status as restricted securities as aforesaid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">18.6 <U>Compliance With Section</U><U></U><U>&nbsp;409A</U>. All Options and Awards granted under the plan are intended either not to be
subject to Section&nbsp;409A of the Code or, if subject to Section&nbsp;409A of the Code, to be administered, operated and construed in compliance with Section&nbsp;409A of the Code and any guidance issued thereunder. Notwithstanding this or any
other provision of the Plan to the contrary, the Committee may amend the Plan or any Option or Award granted hereunder in any manner, or take any other action, that it determines, in its sole discretion, is necessary, appropriate or advisable to
cause the Plan or any Option or Award granted hereunder to comply with Section&nbsp;409A and any guidance issued thereunder. In the event that it is reasonably determined by the Board or Committee that, as a result of Section&nbsp;409A of the Code,
payments in respect of any Award under the Plan may not be made at the time contemplated by the terms of the Plan or the relevant Agreement, as the case may be, without causing the Grantee holding such Award to be subject to taxation under
Section&nbsp;409A of the Code, the Company will make such payment on the first day that would not result in the Grantee incurring any tax liability under Section&nbsp;409A of the Code; which, if the Grantee is a &#147;specified employee&#148; within
the meaning of the Section&nbsp;409A, generally shall be the first day following the <FONT STYLE="white-space:nowrap">six-month</FONT> period beginning on the date of Grantee&#146;s termination of employment. Any such action, once taken, shall be
deemed to be effective from the earliest date necessary to avoid a violation of Section&nbsp;409A and shall be final, binding and conclusive on all Eligible Individuals and other individuals having or claiming any right or interest under the Plan.
Although the Company intends to administer the Plan so that Awards will be exempt from, or will comply with, the requirements of Section&nbsp;409A of the Code, the Company does not warrant that any Award under the Plan will qualify for favorable tax
treatment under Section&nbsp;409A of the Code or any other provision of federal, state, local or foreign law. The Company shall not be liable to any Grantee for any tax, interest, or penalties that Grantee might owe as a result of the grant,
holding, vesting, exercise, or payment of any Award under the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">19. Miscellaneous. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.1 <U>Forfeiture and Clawback Provisions</U>. Pursuant to its general authority to determine the terms and conditions applicable to Options
and Awards granted under the Plan, the Committee shall have the right to provide, in an Agreement, or to require a Grantee to agree by separate written or electronic instrument at or after grant, that all Options and Awards (including any proceeds,
gains or other economic benefit actually or constructively received by the Grantee upon any receipt or exercise of any Option or Award or upon the receipt or resale of any Shares underlying the Option or Award) will be subject to repayment or
reimbursement to the extent set forth in any recoupment or clawback provisions which may be included in any such Agreement or separate instrument. In addition, without limiting the foregoing, any Option or Award granted pursuant to this Plan shall
be subject to forfeiture, repayment, reimbursement or other recoupment by the Grantee to the Company (i)&nbsp;to the extent provided in the Company&#146;s current Clawback Policy, as it may be amended from time to time (the &#147;Current Clawback
Policy&#148;), (ii) to the extent that Grantee in the future becomes subject to any other recoupment or clawback policy hereafter adopted by the Company, including any such policy (or amended version of the Current Clawback Policy) adopted by the
Company to comply with the requirements of any applicable laws, rules or regulations, including pursuant to final SEC rules and/or final New York Stock Exchange listing standards with respect to recoupment adopted in connection with the Dodd-Frank
Wall Street Reform and Consumer Protection Act (such final rules and final New York Stock Exchange listing standards, the &#147;Dodd-Frank Clawback Requirements&#148;) (such policies referenced in clause (i)&nbsp;or this clause (ii), collectively,
the &#147;Policies&#148;), or (iii)&nbsp;to the extent provided under any applicable laws which impose mandatory recoupment, under circumstances set forth in such applicable laws, including pursuant to the Sarbanes-Oxley Act of 2002 and the
Dodd-Frank Clawback Requirements. The Company may utilize any method of recovery specified in the Policies in connection with any Award recoupment required or permitted under the Policies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.2 <U>Multiple Agreements</U>. The terms of each Option or Award may differ from other Options or Awards granted under the Plan at the same
time or at some other time. The Committee may also grant more than one Option or Award to a given Eligible Individual during the term of the Plan, either in addition to, or in substitution for, one or more Options or Awards previously granted to
that Eligible Individual. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.3 <U>Beneficiary Designation</U>. Each Optionee or Grantee may, from time to time, name one or more
individuals (each, a &#147;Beneficiary&#148;) to whom any benefit under the Plan is to be paid or who may exercise any rights of the Optionee or Grantee under any Option or Award granted under the Plan in the event of the Optionee&#146;s or
Grantee&#146;s death before he or she receives any or all of such benefit or exercises such Option. Each such designation shall revoke all prior designations by the same Optionee or Grantee, shall be in a form prescribed by the Company, and will be
effective only when filed by the Optionee or Grantee in writing with the Company during the Optionee&#146;s or Grantee&#146;s lifetime. In the absence of any such designation, benefits remaining unpaid at the Optionee&#146;s or Grantee&#146;s death
and rights to be exercised following the Optionee&#146;s or Grantee&#146;s death shall be paid to or exercised by the Optionee&#146;s or Grantee&#146;s estate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.4 <U>Withholding of Taxes</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) At such times as an Optionee or Grantee recognizes taxable income in connection with the receipt of Shares or cash hereunder (a
&#147;Taxable Event&#148;), the Optionee or Grantee shall pay to the Company an amount equal to any U.S. federal, state and local and <FONT STYLE="white-space:nowrap">non-U.S.</FONT> income taxes and other amounts as may be required by law to be
withheld by the Company in connection with the Taxable Event (the &#147;Withholding Taxes&#148;) prior to the issuance of such Shares or the payment of such cash. The Company shall have the right to deduct from any payment of cash to an Optionee or
Grantee, including other wages, an amount equal to the Withholding Taxes in satisfaction of the obligation to pay Withholding Taxes. The Committee, in its discretion, may provide in an Agreement evidencing an Option or Award at the time of grant, or
thereafter, that the Optionee or Grantee may satisfy the obligation to pay Withholding Taxes to the Company in any manner satisfactory to the Committee, including by any Optionee or Grantee electing to have withheld a portion of the Shares issuable
to him or her pursuant to the Option or Award having an aggregate Fair Market Value equal to the Withholding Taxes. In the event Shares are withheld by the Company to satisfy any obligation to pay Withholding Taxes, such Shares shall be retired and
cancelled and shall not thereafter be available to grant an Option or Award with respect thereto. In determining the procedures by which Shares will be withheld for Withholding Taxes, to the extent required to avoid the Company&#146;s incurring an
adverse accounting charge, the amount of any Shares so withheld shall not exceed the amount necessary to satisfy Withholding Taxes determined using the maximum statutory withholding rates for U.S. federal, state and local and/or <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> tax purposes, including payroll taxes, that are applicable to supplemental taxable income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
If an Optionee makes a disposition, within the meaning of Section&nbsp;424(c) of the Code and regulations promulgated thereunder, of any Share or Shares issued to such Optionee pursuant to the exercise of an Incentive Stock Option within the <FONT
STYLE="white-space:nowrap">two-year</FONT> period commencing on the day after the date of the grant or within the <FONT STYLE="white-space:nowrap">one-year</FONT> period commencing on the day after the date of transfer of such Share or Shares to the
Optionee pursuant to such exercise, the Optionee shall, within ten (10)&nbsp;days of such disposition, notify the Company thereof, by delivery of written notice to the Company at its principal executive office. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.5 <U>Data Privacy</U><I>. </I>As a condition of receipt of any Award, any Optionee or Grantee explicitly and unambiguously consents to the
collection, use and transfer, in electronic or other form, of personal data as described in this <U>Section</U><U></U><U>&nbsp;19.5</U> by and among, as applicable, the Company and its Subsidiaries for the exclusive purpose of implementing,
administering and managing the Optionee&#146;s or Grantee&#146;s participation in the Plan. The Company and its Subsidiaries may hold certain personal information about an Optionee or Grantee, including but not limited to, the Optionee&#146;s or
Grantee&#146;s name, home address and telephone number, date of birth, social security or other identification number, salary, nationality, job title(s), any Shares held by Optionee or Grantee, details of all Awards made to Optionee or Grantee, in
each case, for the purpose of implementing, managing and administering the Plan and Awards (the &#147;Data&#148;). The Company and its Subsidiaries may transfer the Data amongst themselves as necessary for the purpose of implementation,
administration and management of an Optionee&#146;s or Grantee&#146;s participation in the Plan, and the Company and its Subsidiaries may each further transfer the Data to any third parties assisting the Company in the implementation, administration
and management of the Plan. These recipients may be located in Optionee&#146;s or Grantee&#146;s country, or elsewhere, and Optionee&#146;s or Grantee&#146;s country may have different data privacy laws and protections than the recipients&#146;
country. Through acceptance of any Award, each Optionee or Grantee authorizes such recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Optionee&#146;s or Grantee&#146;s participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Company or Optionee or
Grantee may elect to deposit any Shares, for as long as is necessary to implement, administer, and manage the Optionee&#146;s or Grantee&#146;s participation in the Plan, or as required to comply with legal or regulatory obligations, including under
tax and security laws. An Optionee or Grantee may, at any time, view the Data held by the Company with respect to such Optionee or Grantee, request additional information about the storage and processing of the Data with respect to such Optionee or
Grantee, recommend any necessary corrections to the Data with respect to the Optionee or Grantee or refuse or withdraw the consents herein in writing, in any case without cost, by contacting his or her local human resources representative. The
Company may cancel Optionee&#146;s or Grantee&#146;s ability to participate in the Plan and, in the Committee&#146;s discretion, the Optionee or Grantee may forfeit any outstanding Awards, if the Optionee or Grantee refuses or withdraws his or her
consents as described herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">19.6 <U>Effective Date</U>. The effective date of this Plan shall be March&nbsp;22, 2023 (the
&#147;Restatement Effective Date&#148;), subject only to the approval by the holders of a majority of the securities of the Company present in person or represented by proxy and entitled to vote thereon at a meeting of stockholders of the Company,
in accordance with the applicable laws, within twelve (12)&nbsp;months of the Restatement Effective Date (the &#147;Stockholder Approval&#148;). Subject to such Stockholder Approval, this Plan, as amended and restated hereby, amends and restates the
amended and restated Plan dated as of March&nbsp;17, 2021; provided, however, that except as provided in this Plan, any Awards made prior to the Restatement Effective Date shall be subject to the terms of the Plan as in effect at the time such Award
was granted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>cyh-20230509.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/10/2023 11:53:03 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:cyh="http://www.chs.net/20230509"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.chs.net/20230509"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cyh-20230509_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cyh-20230509_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>cyh-20230509_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/10/2023 11:53:03 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>cyh-20230509_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/10/2023 11:53:03 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cyh-20230509.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140489494633488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">COMMUNITY HEALTH SYSTEMS INC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001108109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  09,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-15925<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3893191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">4000 Meridian Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Franklin<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37067<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">465-7000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CYH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>d274455d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cyh-20230509.xsd" xlink:type="simple"/>
    <context id="duration_2023-05-09_to_2023-05-09">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001108109</identifier>
        </entity>
        <period>
            <startDate>2023-05-09</startDate>
            <endDate>2023-05-09</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2023-05-09_to_2023-05-09"
      id="Hidden_dei_EntityRegistrantName">COMMUNITY HEALTH SYSTEMS INC</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2023-05-09_to_2023-05-09">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-05-09_to_2023-05-09"
      id="Hidden_dei_EntityCentralIndexKey">0001108109</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-05-09_to_2023-05-09">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-05-09_to_2023-05-09">2023-05-09</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-05-09_to_2023-05-09">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-05-09_to_2023-05-09">001-15925</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-05-09_to_2023-05-09">13-3893191</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-05-09_to_2023-05-09">4000 Meridian Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-05-09_to_2023-05-09">Franklin</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-05-09_to_2023-05-09">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-05-09_to_2023-05-09">37067</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-05-09_to_2023-05-09">(615)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-05-09_to_2023-05-09">465-7000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-05-09_to_2023-05-09">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-05-09_to_2023-05-09">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-05-09_to_2023-05-09">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-05-09_to_2023-05-09">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-05-09_to_2023-05-09">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-05-09_to_2023-05-09">CYH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-05-09_to_2023-05-09">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-05-09_to_2023-05-09">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M\)I>;CF#B6]>@.=K*?5GPYQ@\W] #/X%4$L#!!0    ( .& JE:?H!OPL0(
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M-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U
M.EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*
M$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87
M_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( .& JE8'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ X8"J5MO%^^WM    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ X8"J5IE<G",0!@  G"<  !,
M         ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " #A
M@*I6'[Y[0%$$  ",$   &               @($,"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ X8"J5I^@&_"Q @  X@P   T
M         ( !DPP  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #A@*I6EXJ[
M',     3 @  "P              @ %O#P  7W)E;',O+G)E;'-02P$"% ,4
M    " #A@*I6'#AEZC\!   \ @  #P              @ %8$   >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ X8"J5B0>FZ*M    ^ $  !H
M     ( !Q!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ X8"J5F60>9(9 0  SP,  !,              ( !J1(  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  \Q,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d274455d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  d274455d8k.htm 7</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="d274455d8k.htm">d274455d8k.htm</File>
    <File>cyh-20230509.xsd</File>
    <File>cyh-20230509_lab.xml</File>
    <File>cyh-20230509_pre.xml</File>
    <File>d274455dex101.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d274455d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d274455d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cyh-20230509_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cyh-20230509_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cyh-20230509.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cyh",
   "nsuri": "http://www.chs.net/20230509",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d274455d8k.htm",
      "contextRef": "duration_2023-05-09_to_2023-05-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d274455d8k.htm",
      "contextRef": "duration_2023-05-09_to_2023-05-09",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.chs.net//20230509/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001193125-23-140708-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-140708-xbrl.zip
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MK;K[2[8O<+O3O^C-5C-HW,__ 5!+ P04    " #A@*I6Z&$I;V$&  "_0P
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M7AC+"T%:";)21*_QM6C#\B)?72_%$Y?ZR/S=B>P43__Z@C[S'U!+ P04
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M#*AG#;^"->+^!?79V8BV^,W1LQ&MUIRR\9-AL\-V\F/<&7)SQ+U\TF#DP;#
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M&07 3,F!#;FC&5FC4C6TJC;%GC8G^3$FO86.5G:DHIO.UCMQD(^D5J,GX0&
MY^0OP._"LJ6? ;/W6FA">P/Z[*0%DF3R1^K:_Y7?C\,9\F.4X&.'K>[U>K;
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MSIS5N\Q\DI%>V@=[!&J&X+'MO9(V<[P78H=A8+FD9:GXR/Q(&+3JV X*NBU
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M575A7K4"9T!,&@B9'[0%/.][7#;3!N,(G8<',%6C']=F7>ITXM5E@8N1FK!
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MMS"X%@PA!\ +. 'A,V<^Q=M"#V8K4&&!#WF:;WO6 '[I^CWG[']02P,$%
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MS.\]4,8!MWJYKL\HD,0W8C!Q''G9H&J'A[2H%G"M8&]0W\X.']W_DQ7-9++
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MK[M/<"HNR8/HNAA-+%' (/3W@$H3:W,*_)6H6&71B]3G0F$.=FR2S2)_2@+
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MZ!M@@_MH^L.0"9^O(7LWJ%(4<!.[.#2WRY:<%X92M Y1[A+<$IL8%PV2&*7
M.1/U_7QCBK&[@:BNAGW8IM/A!:F-LZB"WZ#><% .,$X$=0C@@<=-<KLW6WUX
M8=D\)7/-/SXYB(P^GA;G@F.:8AE@V4S:F;S7C6I^-6]FZR5[5G@SQ$B)8<R#
M140KP%E8>*1ME8V-=K$ 5=N .:^FM^2(%9&UNR@JJA?=:5?JDLWQM+TZ<E5U
MCN&0O$F9ZQ1A-LAOCO\ZL3^YV79':BLM7WO95'%HS-')3KMX#)J5UE&DHJ_.
M<A*);ANY$+?N-E1="-)68@:"Q>V)Q:0\#AR J1V:M75W/DPCVI@S$W9*;QG)
MVV!.CNG9X^HCN' #9O!HOD[G^XM8QVDGN9TMVW+Q+/S@>P'7$ 3ND_W3?Z>,
M-.FUZ]43YZ;<P"NUS3VYE!,'2ZJ28TX2=@C(:$ LV#O&'&X8[^J &')?^*4M
MH]XY<'28I,>ESUVI-7GXHB[G9_$3Y]<7^,?,M[>[ZPX7/ZLZ^=;L_D:A^WAD
M*O(1VK5D\'S:U"J2P7]E[;V^9EIY.Z"0':@CEIFL0&\"*VK=R%V-$\^V6/,?
M]5U:?NKIT/'A]@]V!'P&M^\NL&4,DM;J>0EG8)T&<H4YLK[1:_ E>K@>??5P
MW6(GFQ@^]5)EK&"?C?_)Z=6FZ$2"'JM.BFN6\P3R<(MKP@&=76F4T+[$N*G.
M4/JL>%QOU$,.Q\7>["Q&I.Y#(*^F0;MRK[HY<.E<B[%R)KAZ%"3.&ABOE-!0
M+5FD^>(91IWQ"%!J8Q^]7!W48FG'9@E/P#%APB3[2T[;YM4CRDV2,OB\@'2;
M!;_OVBZ-:ZDF!FK+:G7)P2GOD^>2PJ8H$"T,,["DG(:O@)"@E",.[-9S[W9_
MO7 S3L["_CKG<U;#!(AI3B5DM/['B@B5# \JB8D),1&%'%&]2"I_(/J3!!<T
MCB-G(4-.2[A^*W_XDP,:F%Q4+3J\+JAVQFH]K!R?)/M(&)H@4F(3PEZ*&^[?
MH9ZEW2RZ*KN>"QJN9SP&*=%NDV _VG4Y=S4SJ  W$&_NKPZIWDX=-9<ET%?U
MGH1::ZKI,<6GAKM!)33Q2FMYO&OSI?O]8;@.[GL7KD6CDG'+Y4#H3@[&W3>N
M"Z)?M>]0Z7$(8GC\I+<<C4(MLSQOUM.>]G*$^%$I)OXU@/PH8&IXBCF"Z_PP
M<?T;,ZW4T_MP))5'7/_:E[VV]:[_;FFJ3+'?;*.&FR=8_8PZ>(GQ:IW26C[6
M0QAV\7.JB;O0\GJQF>:5Z\-$P<J!FS0?*KI$[>(D]25=RF6#7ES7,V#,?9L9
M[^W8TJB=L/E;G>X> $/.5>Z-F2NCHS4P)Z9UX5KN\5JP0-;1W0->GG)#FG20
M*A$:X@Q4U_8GV8EG@SN7AMT6(<IN%"#*;]V=Z&PGXU.D?CI#IV+:&/N"?8H4
M; M#6*JXW$;(S0KR;63R67S_I_OS_1O%A9?.UXMV/+D#KJ>[P/>&(3[G%W0.
M0&<1D)A5V+DJ8NG7H/>(4;3<]8& +MY>&%2M"[H2;DPCBRK?XS_24S!5&%D"
MZ<P9=-,&]T/Z'6_L4V4,L@TKW]8EQ@Z3\);3&!;/K@'9PA9P#W5F!>2$>E0Y
M3@1(YS;8BQ:0FI_9*V )EUC2O@]*3WB1*VXG(CC?@$@J!(+JLV&D4!<:38LU
M)35&-T@]SM+2=U,L6PV\L)?M"(<P:CNM^YWML8ZYET/J#%MJ>O/9Z]$VDJ1=
M8P3:O[=\TVW^LJAQP\X.LY%]16=9]O\?7]GCK[ZRCP0]/3O&3LBHNY*5QG)M
M#]BF9XQMLG,9TV!'?0PQX&DPV#CB*=!**+W?--Z)E-W1&BA_'&4W'4#?KNN*
ML/EBE%WD7/ #IRZ1F.Y1R54>Z;4@2PV_D3H*^A:+VTH28>U/?KR>8:6)(0UY
M;2X([*H"IQ(I*B(3<'<@=H)%+\+T_IT3^N.YIC6P\9^"4$1$"/LYR1#VR+!M
MNF/8VUO;= /#U,9KBO)N6DD-0C[H6G@[R#A<W6HJ)45J\D\8;_1%Z6!*Y H!
ML57'-]J=H3GQFY549E,X5!$'>V50+Y(B89J5;U0)"]G@P9@CB$@='F?CLR^2
M3(QWNM*<;&%@8Q3.Q[+N>BIXW<%-[;0^".=7J<J6?!=UN5<N-K@A<G]L18>1
M:<@$,O?^*.JR:>N3C=YV5Z<1VA:ZL.Y&G4ZM:*!)[\N:_8?):/[)>7(W-]U[
M=OPP'Z J1,468D_!49)TU7./X[#NSPCM;.BM@KS1DW2*DIE..3#@01:6.2/W
M\R.&*T!?9M_LXYBFFYP.;[SAXT"<(?L983Y=%,,P., T^*\NNAZ[GSJH]'!O
MPXHNK%8(9[*M<;<H(JY?KAZBZW4(+U:QR@T(6!UP$2YXX"CW;64T5KBY\_FP
MDV),909UM^5*2)^6:P\8U^U%P[.5!"(Q;K>6F,^#IVS:$;TGRCPRD5=.0HJ]
M=@-M>1 5M?75"%9.<0&[J'R+8!T'VW&?SBK.AAI.JN!2;T1WK,D;W)\F3=DY
M^5VBL'?;5]1,HMHI.J*"!(62#<L;GA00M;Y3TZ@VOL6)RS!)=_BST,DUP-GN
MQ0X[C>TP&YWZ=$/,UWC_:HG]7V2)11JMR9G);I0R$Z::'&\FHK'X@NE>GH@T
M?/OE^KF>?/5SW4DZ1^C=9C)SH8$T5&QRD"#0JF,MP#W@,:6]<5AS(R1]R#D8
M^,H:G6KW](YMAO M<+M5DUQR/$>/*+L%KC@6B[WKM V,3.R2MS': ](!#!,[
M>-/DC5 D?+;D#9N#DL[>2,3?$@I"D/.XB8 "4 &^R@!'S/(W0O>/L;2+U'1N
MO?HE SKU+#@JJ\M&81G0CK9FCCB\RX;:!OG^TDNR7;-+T#OVQTLON97J1Y)=
MLKI.9Y<D^=HMIY4@)<T(&>H-R-'+8#--LL^4:((,O56D2(_MNS?@PE+Q7]#>
M&P$\6AXT0'59C7XU<"CX2F153^VN.JLW[L,-P[4WDQDQ.SC+A@2V@;9&DE*D
M&M5&<6M=<)NR6$Q9Q#S ^N!+R(TFS2K&O.T?EXF?TIENT\[]'#D![\\_(SR?
MCP\=TX&RMT4U8)71MV,3'2N"V$>3W1GNGT:;#K'^:9UE"^Y?TO<Y3]WUD=XU
M"R"ED'\TJK]SCAN') _<"@ET_W#)'X_J!Q/W#P'KS^X4U>]C,&G2'H7S5ZLM
M![$-QB_;=6LH_I2=ET;T3P[V!>G?I%?OAN0?CO"E8N5W$;CIO*$ -Q]XIES:
MT>?!S:N_'X?</VR>6;4I5FG^O#%L_@M&F3W]ZGV[M2C#@Q'M<G_Q\%=:,=N4
M.TPKP!B?'(+F?(=LU.C4%E0/@].]0.:B#*:NB5*\;W+@5:=5B<ZXRW*%84#3
M0?#5#Z_?OWQ!JN;\WVO29/@CVWF/D4+4I"/?7AC7=:N#^=[KBP^F1.Z"DCP.
M+^VL=.+TN7XA-2RQ(/=_UE1."\/L8/;*S_1W#:RVZ!F(BJ8*K?G#MK7)4<-0
MN_X4974+W([].(<?]/W3 OL,3WL\G7*%?C[XSG=G[,[917)!\_[@Y[W&V>(3
M5'!JQLU0_ BZ@W.XME3GW9^>_GD!RR:7&?/83LLL<2.CPP\ZQ%G;=)WN#GYN
M]YX_S@Z93_@X*9P:*4#X\V UB[JY>LX?5\$+^'!I\A\27V3^0%ECUHT,?RR;
M/?KC*O'KYW#D'SXD*,(?LMGXJZ;]';^<%1=5CX6+\=O+^ [)?GC-"-U=N"?T
M^\L!D=K1+H<T[(R$\'?^AWRRL*JK_ER_=%BX%=4R:[&O(I6!EI]CZ62<_ <W
MRN '.))^W3<]8Q+:4OR /#_^D>,B(,.;935C, $JR-1Q](/98&^0-B':$?M"
MHHD):DE0%,^A[(#:L"04D7#!-;T+9WN$]<><^"]6O_,%4P?3Y*!N5F?WN(L!
M.C3@>?[K8@UL=D;&< OWH"_#![,.)@7V,E6L7H%& 1. !\["1I;R?LU$4RNJ
MJ&=K+M^+UT;KLDZ+&AFU<Y5+#^S% AD5:T#$35CU\=$$UT0A!804DPCKPUJ[
MB [;$#*H4&OVJ"#<SA&]<!$Y>T?9V$3P'JB;;6F6ORQ1P1,K@RNC:QW\N'HA
M#W?I2/(Z1HND?JU3K5P<'H63$V^SML*2?07W\OM@;X2#C4X._H-UR2JN4(X_
MQ"P-_3,UFMGF37E  \-S5"K+8*$MA(/9M\?4(WN(KWBWGG;57 N?FR_0+=39
M$HIF2S5%?+%M6L44"&7-J5!\B+ O8.1)&<?Q.6:^R&/T(^D42D!;IFC*<JFT
MGA=L*EK,>*HS]%=H'M*HCE*@$#C#+RKI:T?%ACTC:3%C9']0.)-# Y889C*^
M0J17HH2';*'OECK4U_+QQI);T*9L#HF'WX'.[.&X6LO 1==H0Q5G,-MN(\3Q
MD.IY70LGVO#+(P[H+&J!)Z+*4\PBL/NL:8%ADZ&*X8)"\SQ%"R$O!ZD/V*8A
MX^8'Z,ED,OH #S7M'&@<&WVO5^L.>0*N?-6LO/PBG%UGVB5(>?L"=JWMLB'@
MVB*Z*BJ(V%5=[S"7M)B5[:DT.+6[SZ]^=OR02II]IH)'"6CL1Z=NW3%0[-$M
MQN)P@2;7=;@KC8)1?9U;\BAN\?2D$_<'#B[WCKV&X.Z@-?;)_>/L-[JE;"O:
M?*^[O%6#\*'44L( R&!^JNPD (.J_PV?<7</68S>MM8W5 ?^XVQR/" 7>;&I
M*4#@8EEK1X-'.9*M^_PQ_I5G3RF0"T*^N2RC6$BJFE3KWH8>8E3DN: QQ8<T
ME217H+#K?\ ^042ZHI[D:@?#]N0A44T+<5>KLD%NO-S>B4TZ%_LV4]SY8MTB
M?3LM''N(IP@J@$ 'D11$=(I!C4K&@C(AVDO44#)M@Z<S2IQW)E*2%3VM4:VA
M I8_P0N"Q.#4@-B.3_M^.0^IZ%Y?L*_RV5=?Y<>R2 0-.6%?9._IGC@#ZM7R
MHFXDU(6=3HAV]Z 3O]^44.$47XH?2B<;Y$OT=[K@I =$Q65 ?*UXC63(B+ !
MPL4HDL0]"]U>M:)7J@*#(8&U8QVEWT<%O/%>Z@_X'1QPT-A#&%/&5"1GM;'K
MT1EKP($=0FIL7L1$B\X;QEU1:\[ER+!'<>F;R<$GPB'\4MUVVIQ#UGO$,/G\
M/3!.3L&0<KX0#K"QMLDQW!_9,5;]MV!;?!^-ZU]OTH>#^6W(2GDP$O%S+=%J
M$]T6K(+!KQM_D0\KPTN"?%[-$I5D3KI6=<'-(;TJ($XO0B+0+0#SBJWX=,<M
M[7:JU.*$K9*,;VN'XCFWNHB_R>3Y&[XBA Y.#N0--ID9J;%:!<$)?.JC%TF+
MHBP^?U;6_!FN-[U0E]\1=2OO)4.,S\GM0"YZFOK*C.8_.;!HIX#[V8F-U4VX
M:T3D"\4$>Z)4EKO+ 5BPJUW>ZQ4J$^BF8I2,GH-EK*OKP'.JEFIP $<1W"+L
M'8&DA>HW["TJG*"(41'Z;-G,.=0NN2SS<J'*:G"1'YX^/#P_.GQPY-UF\U*P
M;K6#0BFB&:]SWP?#=-G#TU-L532'?SRTHU#M4=5<<]_E==78G1;;)&;A:F/@
MVL:8T,/[SUX$TQYL5*&[1,-=->MZ[D=+"(ZM;R":GWKO+79U#)<RNI*/7 4=
M@UV*0)*W'$MZ[#WA/U\O\E!9V"1R"HL2=-:?1[7[)L.Y6().TTG]R/8,!,;$
MAQ.Q[3Q;E5>YA4DU".I>D('8&[Q;ZOX/W<V^&(2Z$466PJW=Y44.0]R6I!>&
M"5H&^>Z5S'P(8[FP#-E%#5A<$(8JY,R&W4798&)^MZ[Y<\HEY+HIT2K'3O<.
M%+ 'QOH ?4L<W>^-%_=YML$7N1^5+.F<MW,^1C_)*%*:O*5\&SK;63C,T;<9
M&K%/-&C!75?_65=SI^V##DZQEV'TD@):CAMFR[(]P[A@2Z*HJ=T8X4.'VN[*
M+)#[71WE0VU$Q2;^+?J+H'8CM#?ENO:50 =*WDY<^ P;/TE<@>VTJM7+C^)9
MP-Q:D +9M4^ +.PQ9&5%U]J 4=!K/U"V//-W'(D<U^4\T 07'J16>$N48O%X
M9'#*".-L@.O//-?"7]LI853!:ZB@HI'$;(*SEPY7[O2-52O-<G?JY9ZHV,=.
M*\N=D"HV:9]I]K$>]*0/= *%D2.+T>9L$226:E!P8(I-T66@4_]>,2"XXRQV
MS[]S*1" M@E<O&OK!UN!#5NVX@A#NJ U"ZS U!;"TD$C&Q8?5USBA@;86G:'
M#I"G/CD8GWL^-GFMH[GD\J6?(DNRW41)XMHZ$?&E.@5/[W]U"GZD6)9T?',3
M-M<X3WB$M!&E$&MG@H )5U=N(\[";^ 5=>U$DN52*EB&[+:8'$37M]1>]SJP
MZ4&LCG3'3+C8)GS#.*--)6.- F9*(/GL9;B76 EF4 [<V974/7FL6ZR(UN+L
M#-%+_<#*/]2MR]Z0T>F &0%O0I;$'$G?*NCZ\8'5_'%E1UGHH;3MG/+LG[[I
MUL@\V!LQWBOWZAS3ZLP"1Z<$^M-B_)"4XX?%3<;?R]&CW..KB :E;%M$:O$-
M<13/F!G+S[DK.^5"&8'BH#3O4Y'R6#4)"^SA><?%HD&M+(SW(?#M(?YEO61Q
M-PU]>W@O;* K'//TCU1"%KOD&0C"KTV/>^Z[*CM#SE6_L)$[O<X$4""HQPY0
M@UP@9*I@F@K>-'3B$!P2 L7L=;IR6E '(*@$51@#TQ$%ZHR*O"%&T@?A$'[=
M60-:B&KBF^8E 7JO!1Q]N^&0[ZS5V>O%T%DB'8@W.T@CQ^CA"S5QJ*(WT[V$
M4N#2(M=H!#QVS06V%HNJKJ1\))8_.Q*CB,P3LJ4/?S!CMJ54<2$^($CP@N="
MTZ4<Q_:RE(54#/2XM/QQN(JP)SC[X ?DZ&N[B*@$[;"#&91<EA'93\*&*AS8
MI)N=E_-US59$&G!%&K]U''-!F[;TBKK"\!:@"[16C72UV:@2ID6Y[/#BR<&X
M7FKL$0(,42QOG0P/-)(8B3O#_M5.66VH6 <-V;DZ#U\A1RX)P],9NC$CT/##
M> @&+B#ZW[F<PA^DM5WJSF4WOW+:S49N6QY>'G=?D(/'M)G:I".&ELA9N[2]
MX6T(>;.7H8>M)A:BU=1M3P[9^@-V@? ,8,OO.4$DV"[.)7'YU>(@L8+ %YD;
M;.>WGF>EMGVSKL2OJ):P[\C#0.*X$J9:#9Y5/+Q7SSTGZ^/<08HBJ#6:CH;;
MV=GR;@*T25=GYVB#;:UMZWDH@Y!2-A)C'"Z*H'#/K8)M4CS',@RIF,ZZECTI
MY\_QDWP0!AQK^V)*H I,R4QHU%<E .,6;/]JP2TJ<M-9HBS:NL(3HCA UQ%"
MA\H0\Z6BH,(@+/"<8QD_)L@DD9LU$C+<0"I!807["U/L=]-RL8*%-.T80?SZ
M-/YB=EZ5ES[YNP>V5O:!UX*2,S:IGG?%(G?ED1JKN TF.=CH[3QRQ/,HM]>X
M=4'B?#(OW)D+;B@((ZL(EI']T)ANWN,HDS@')5"(8K\!EQ))> ]"?6M$P(1:
MM^]6(RB\T ]9!-DGH<ZA\4&,<+F612G,CY-V:$*NE\O0)Y^0@&RO#P&.M)G$
M>W$WMR7RB%[#@\'_UF4!G"%H/B(^@$/&?[@(=*#6)IRP',:EQ&QRLQ*%?[$^
MQ9.O/L5Q9OLQ/L8A20O]LM\^#MAJ!IZ)Z')^$>I_8_I5AFI]B-5@I\?LO/ N
M-:7KA5H0PW$.3=0IS[2/@KKV C3!F,(65D_VW($02AQQ C8.%PW!>)0PY>L[
M;Q^=,;WL;[)QX>+#1NWBZ*9N0VHO=V._X48?G0:^$BZ8VW(6[CJ/I*N/YP4Z
MG9G8SG["A"&_(1\PD(-;.?='^QWW;X%>;M*N-MI$QF_BO3R[JU2I_E-.IV)5
MVWE\G)A6WN.EM7YBT+TX.@7VHO1%!_LG;%X*@C+,RQ1?!GNL*(=,D;W#*EC*
MM$(HK_=W+?@U&(1E6 ]9>N2G^9'JOC2M*[^:TDOP^;\VS1R,)7P^C^J(2OHD
MSFBK_MA?-?>P&).KP%"V58,8;# [&-0]9O"SMFNM*>ZWMPCG[0]J<A"=E(%&
MY[O-=A_J<.! EL"O>C(M82<DG6J\J3/LHUR[_1M8P !^2]_N<7[O_)')6T\U
MYFYH2;DT819I[FZE]C!M!P=^DI$N#%$JP:@(+Q(-0,SPWNV/7NRZ*Z^0GS^?
M' P0"7DHQ+=OZM!?M.L>7B8VT5?;*S]<5&U@R#1M!50$$AJ],QE73=A]AU9A
MX(>U,*ERH -O/ 5%GH0Q&2FZK/)TU]G0KMU0X;J+W,>'B.B%;8 )]WO,7WBO
M_H^JXW3G.;6:;RAQ#=@;T=1;# ULY;0GCZ?W'IBZ/<MU?5:$?JY7&NY_,?-M
MG.*TATJW18IAP.EAZE^[P;&O4MK?/@OR-<F#I%WAFHX)J>Y'0\TQ3C+D/AFX
M=E]'?"55,T0/\2&[@@.B8G.#C.^O[0SW$ZA]/]3;J#$O6 DULF+GU!V&EA_K
M[,,S2W _.H 9UFCI7(5+*7S.)[_#P,(,:2@?'I8T&"K_@G(6!>Y=W,U'QT&B
M'<&N8)?FNE.6['ZQN0$&0>*Q6GO(AX<5< =+G*29>FO7Y0O+&O>S4V%]CS_"
M)X#$UGP^I"6T-U=8DX\,8=F2MZ6KV2>H8/C%Y. EY2C!=JR: 6XBRA;J37;9
M>V=JX8^P+539FND-L*WTV_$(WV.V!VV1#8H_4)8MY;XU\BEN5\XY'Z*E=]@"
MT+UQ&\#PRVWI<7KZU7]VB[)U)1ZO0B]@'F02Y4)9G=P(FQ>JL: +](50FCG!
M1&L,5+)4Q+N'$:"B[LO68)*LN2& "2I+-I:0)SXSIRI?M2B+5Q85&*FX28#@
MJM$ZX92'=?,5STLLP%6.01 )=('?A<6GN9O[.6.?*895S$3V].=MLSX[9R _
MEA4NNW4=L&^.VNU#+H>JK?<H\N'0#KK]GAS4Q17"B,_6&C=I/6[2RG Z0U]@
M(%WIAA/!W!LQ):'L*L:)* C3U.YF-1#/UQ^J ;8KE]?.>@1=NS2('M]"8I#<
MDX+":/8@+AD5E&UKOOMB(2!:J2G9=KFO,+@P?3#V1)O4!FQRH=<\2]UR])8R
M2W#U0SB?TI2D\_<[?H?%_([<\N35'BN;^WEUL,?'VRT.+.<#6B3A*'TIGZ':
M?>>U$(IY<V$-:E)4 O=Q@/6C9%.JHHV<:LG]AE4%D?)8P+YFE4=28N"A:M9=
M?>WO7*5)LL I6RJ/IEH?#(M5%'M]FL(96L.0];P+4&-:G2_/$55N7(BMI^7>
MD9E7:(L,KL)>+CU+,5@2#SKW;V<G'XDF*;8D28$JRGK-OB)7:"R[?#.*8#+J
MZ^#\(B.YSDK0(>EVX:617%"I4S8C O^XK.F;4?:3X^QGMP.XYI\KJ46U!VI]
M 0=7PP7JQ:@5 @@(9 %_R@P'-0NG:W+X.-^!6(#EA_,"!JTN2PUHH A!)_19
M8#;ZRA7^#O3-)L#KYW.%G*GZ 19^UZQLC:;&&BD)]FW<]0)<B,- ?M]8)C_?
M3^'"T36B1E7T78.FS "!)3I7Z;I7Z9VANV23XXR-M(_<:");3M"\SL#2H/GP
M&:8SBTT\!G6RP+HT82-!_>NF>1OR.0ZTEWXQIB>93J^POF?BE>J#S4V1358B
MZLHU&K?;0L4B>>&)%5-?6ZQIVW*3#M3)@P)7/I)E?RL1)#P!ZI_RV3GLT^/L
MK5,=627CLF O2%06=?<\^RN!B9$?_5QLQOM^)CWRZ?&)Z0='/86Y5"7LTZ+$
M*'%-:O#0TV%ZM-6U'%&'A4XJ<G3'C9M"!6,UMR'M%.:7^']QY?3U=[U$\5Z6
M->+H2R?(@9M0Z4UQ?5+5C 4(6YX<C0%&W6I67=0>YKT'E?TIJ.RHEGD]V6/X
MO:D#BC:7$.!N$\[2C)AA(AES(Z!S6'# 5KZ!/0+;;EU+VR)O\00PW.@I)0_2
M?^AT#."&AU1::::8_B[*E>+R"<O/%P&U4L;54V_&FGHBS:J@CR6J=%3$VAB-
M-D<IKMGWY5:J.WWPU0%V>Y?N0>3#]4W3I<:OH;%1XHI"40223=X7E8*>FK-B
M#7P*K@7G<B/<B&X#R:A4PV]WD<?*#3$>^H,TF.FMM6VNYS!&Y<K=V/G:$%GO
MF/9^1-%#[IEMBO.YXF]1 1/K<!*@W2(N79UT/27+T#D%I.8T+';Z5&R.L$)!
MM=NM^\2U,^[6O-WKML-Z[SI##6?:]KOD6/(\TKF25%'B'["@:T/QJQG/ZBD1
M\KPLZB'%4<L%.N$&*'G:S*\W>-O(*^G"WY@JJYV6(I":L9)'W$<R1]H240@U
MZV/5)!S#3C*9RGZ*>>1"2:W=9E05$X5?<_7ZZ>%E]NSR\.3RY Z>8XT52CM@
M)4(J$M,UI1JHI=-N;=I+AYY#T)QL,EHL?N[V CU*Y;NRO8OXET*T+1LZ9'^V
M#UEO3H!U-X7+.E?1;7!N[[';@$;ZK+G4DK8%PXVP>GI)+;?-I?-1/,_>WOG+
M\X+S?D^>/7B0.X<5=8F#WW$F5OAK5X^&&EQW6+B]-ZZ=\@,8'(*-E29BEHI,
MMS+;1LSE!+ER]EK+9*29N&@IT4)P2A3B/WGXT!?\L&S:LN;W<=:##I^Q0]L5
M\F4T/9Z^]M:TYY*XP6/AF9!)2"16J$6Z!#G<C%YY^DHZ>=("K\@]UIN;H@YX
M] -S7%>H*R8G!1V:M1&X2[]W\-;LLH(+(45K; ]G5_R IU*%]<MM%1JJ8.X]
M*=&.^5A#0*PZ^#BIMH.1B.!(T'FAO>EYDGM)G6-,AK]'-<6TZ.O"ENO7::HV
M>D]][>X53( C6ZM ,9+.>H*FXVU81>T8JE8+W88MQXTH1 )#S;0KJEMH??LQ
MK/,QAE.0)NN*A-<_#8Q-ZIL'9<X1H25=-F#;=C+'+C3#R[DIQ3DLU1[1 ;ES
M24&IWKGK[W.MZN" 3"A.&48D!KDWSTGXNYT8 OJ2-11)!UE+V1>IYV6),99,
M5']  <<W*LG0#_@?$>D AS7&W;QK0GQTC-!B)0NM U\D@LMVB(9([;<'BN0@
MT\SJ6GEP67!>\TM!36)Q4>ZF>?-Y1^;(\'!V.9#7 \'.85D&?\,<KT?3#H*4
M ]:_H^CV9F($0<1Z7MPGUI7\BKT8>,K"L+F"OLG,0\I ;Z&%O+L./G9SV7*H
MRTODPJ9T7JI\F8H4/"+%'"D* $/)824?N5TANI-% RTDRB5(W,[8_>G-5)=/
M*(UIJQ;TC#FYE5WJ'&Z-;+[H:QZ+K+UIR#;"]C8NC)( QL4S>\ZA_%PR=_VP
M>-RL9OD6.^RR92#]T^>"]Y?>0&5A^RP/WIF;L)BOL!<LUR3Q[X+)[ZH/]Y9
M&>=1"H'I^:S8,G8LCF<!4&T\YX<_-N6%A3TTU',"3FR5FV"2>*PD%N44!]=2
MP65YTPR"C"XJH$7J3./35-/7W&>X(Z8YSZ:5+U?AZ_O@8O%W28>#S^JOS*<@
M[B7JZYRZ/AA%]I>T& ROZO'DX$6-=^?L/*!J%GH=QW,#-"V[*1NF9Y&>VB_*
MJ.7$G^ESP_ORV!TPK$^T^;+-FY+-$J>>*CXUR8?H_6Q27I,'Q]0W*3X K;M$
MCATNETOK&4H_,?[S3+H&U\V,2\NBEE2=K= KX"P!6D@0R\<[SD8I?F7S<X0+
MY.[X)!$):(<T,5J^/K#DL[XJ4^ E$DO RH4;YEJF(7?X_CPH]#C.W;]@5^W#
MKZ[:CXV//3O.?@&U"1/Q5V6SW@M"^1DCE'_RS=Z1%_X(EVM:S'[/WC@?JG0_
M-B8<ZGXBL[R+%[_P32V\(K*Q?X@8#XRIW!C,27=H(+O,QYA[5RDV'U8)9@^T
M\Q?XM*^& [=D:I<7!456%9]%243 R-IF5<VRBLP$=FVS'XT:[S([$/:9-HFB
M.ODPRUE9SK$;+'E/O.?#]7(5%S<*VK5"9L1.(6%:7_N2 :+Y!4422&"I@Z+=
M4([6>3!=;07S&-JEM7MH6+:P'^+<CIP$,SIA6_JJM^ABKI93(*C [R;^HB"]
M01;1K"\TK#Y3 C5._J#K*V^TEHD6;27("G.'[(\SJNX? *5TF:91ZB93)?3_
M@;+H0Y'H:;6;LG!W+_<;A/^TNV-\8FX?HO..W$J^[4A86#^"B40E ]03Z3E
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M+3(P,C,P-3 Y7VQA8BYX;6Q02P$"% ,4    " #A@*I6*C?R]K0$  !R*@
M%               @ ']"0  8WEH+3(P,C,P-3 Y7W!R92YX;6Q02P$"% ,4
M    " #A@*I645,4OVD7  #2Y   #@              @ 'C#@  9#(W-#0U
M-60X:RYH=&U02P$"% ,4    " #A@*I6(AX'@L5F  "2" ( $0
M    @ %X)@  9#(W-#0U-61E>#$P,2YH=&U02P4&      4 !0 ] 0  ;(T
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
